Systems and methods for performing surgical procedures and assessments

Description

BACKGROUND
I. Field of the Invention

The present invention relates to a system and methods generally aimed at surgery. More particularly, the present invention is directed at a system and related methods for performing surgical procedures and assessments involving the use of neurophysiology.

II. Description of Related Art

A variety of surgeries involve establishing a working channel to gain access to a surgical target site. Oftentimes, based on the anatomical location of the surgical target site (as well as the approach thereto), the instruments required to form or create or maintain the working channel may have to pass near or close to nerve structures which, if contacted or disturbed, may be problematic to the patient. Examples of such “nerve sensitive” procedures may include, but are not necessarily limited to, spine surgery and prostrate or urology-related surgery.

Systems and methods exist for monitoring nerves and nerve muscles. One such system determines when a needle is approaching a nerve. The system applies a current to the needle to evoke a muscular response. The muscular response is visually monitored, typically as a shake or “twitch.” When such a muscular response is observed by the user, the needle is considered to be near the nerve coupled to the responsive muscle. These systems require the user to observe the muscular response (to determine that the needle has approached the nerve). This may be difficult depending on the competing tasks of the user. In addition, when general anesthesia is used during a procedure, muscular response may be suppressed, limiting the ability of a user to detect the response.

While generally effective (although crude) in determining nerve proximity, such existing systems are incapable of determining the direction of the nerve to the needle or instrument passing through tissue or passing by the nerves. This can be disadvantageous in that, while the surgeon may appreciate that a nerve is in the general proximity of the instrument, the inability to determine the direction of the nerve relative to the instrument can lead to guess work by the surgeon in advancing the instrument and thereby raise the specter of inadvertent contact with, and possible damage to, the nerve.

Another nerve-related issue in existing surgical applications involves the use of nerve retractors. A typical nerve retractor serves to pull or otherwise maintain the nerve outside the area of surgery, thereby protecting the nerve from inadvertent damage or contact by the “active” instrumentation used to perform the actual surgery. While generally advantageous in protecting the nerve, it has been observed that such retraction can cause nerve function to become impaired or otherwise pathologic over time due to the retraction. In certain surgical applications, such as spinal surgery, it is not possible to determine if such retraction is hurting or damaging the retracted nerve until after the surgery (generally referred to as a change in “nerve health” or “nerve status”). There are also no known techniques or systems for assessing whether a given procedure is having a beneficial effect on a nerve or nerve root known to be pathologic (that is, impaired or otherwise unhealthy).

In spinal surgery, and specifically in spinal fusion procedures, a still further nerve-related issue exists with regard to assessing the placement of pedicle screws. More specifically, it has been found desirable to detect whether the medial wall of a pedicle has been breached (due to the formation of the hole designed to receive a pedicle screw or due to the placement of the pedicle screw into the hole) while attempting to effect posterior fixation for spinal fusion through the use of pedicle screws. Various attempts have been undertaken at assessing the placement of pedicle screws. X-ray and other imaging systems have been employed, but these are typically quite expensive and are oftentimes limited in terms of resolution (such that pedicle breaches may fail to be detected).

Still other attempts involve capitalizing on the insulating characteristics of bone (specifically, that of the medial wall of the pedicle) and the conductivity of the exiting nerve roots themselves. That is, if the medial wall of the pedicle is breached, a stimulation signal (voltage or current) applied to the pedicle screw and/or the pre-formed hole (prior to screw introduction) will cause the various muscle groups coupled to the exiting nerve roots to twitch. If the pedicle wall has not been breached, the insulating nature of the medial wall will prevent the stimulation signal from innervating the given nerve roots such that the muscle groups will not twitch.

To overcome this obviously crude technique (relying on visible muscles twitches), it has been proposed to employ electromyographic (EMG) monitoring to assess whether the muscle groups in the leg are innervating in response to the application of a stimulation signal to the pedicle screw and/or the pre-formed hole. This is advantageous in that it detects such evoked muscle action potentials (EMAPs) in the leg muscles as much lower levels than that via the “visual inspection” technique described above. However, the traditional EMG systems employed to date suffer from various drawbacks. First, traditional EMG systems used for pedicle screw testing are typically quite expensive. More importantly, they produce multiple waveforms that must be interpreted by a neurophysiologist. Even though performed by specialists, interpreting such multiple EMG waveforms in this fashion is nonetheless disadvantageously prone to human error and can be disadvantageously time consuming, adding to the duration of the operation and translating into increased health care costs. Even more costly is the fact that the neurophysiologist is required in addition to the actual surgeon performing the spinal operation.

The present invention is directed at eliminating, or at least reducing the effects of, the above-described problems with the prior art.

SUMMARY

The present invention includes a system and related methods for performing surgical procedures and assessments, including the use of neurophysiology-based monitoring to: (a) determine nerve proximity and nerve direction to surgical instruments employed in accessing a surgical target site; (b) assess the pathology (health or status) of a nerve or nerve root before, during, or after a surgical procedure; and/or (c) assess pedicle integrity before, during or after pedicle screw placement, all in an automated, easy to use, and easy to interpret fashion so as to provide a surgeon-driven system.

The present invention accomplishes this by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”). By way of example only, such surgical accessories may include, but are not necessarily limited to, any number of devices or components for creating an operative corridor to a surgical target site (such as K-wires, sequentially dilating cannula systems, distractor systems, and/or retractor systems), devices or components for assessing pedicle integrity (such as a pedicle testing probe), and/or devices or components for retracting or otherwise protecting a nerve root before, during and/or after surgery (such as a nerve root retractor). Although described herein largely in terms of use in spinal surgery, it is to be readily appreciated that the teachings of the method and apparatus of the present invention are suitable for use in any number of additional surgical procedures wherein tissue having significant neural structures must be passed through (or near) in order to establish an operative corridor to a surgical target site, wherein neural structures are located adjacent bony structures, and/or wherein neural structures are retracted or otherwise contacted during surgery.

The fundamental method steps according to the present invention include: (a) stimulating one or more electrodes provided on a surgical accessory; (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and communicating this relationship to the surgeon in an easy-to-interpret fashion.

The step of stimulating may be accomplished by applying any of a variety of suitable stimulation signals to the electrode(s) on the surgical accessory, including voltage and/or current pulses of varying magnitude and/or frequency. The stimulating step may be performed at different times depending upon the particular surgical accessory in question. For example, when employed with a surgical access system, stimulation may be performed during and/or after the process of creating an operative corridor to the surgical target site. When used for pedicle integrity assessments, stimulation may be performed before, during and/or after the formation of the hole established to receive a pedicle screw, as well as before, during and/or after the pedicle screw is introduced into the hole. With regard to neural pathology monitoring, stimulation may be performed before, during and/or after retraction of the nerve root.

The step of measuring the response of nerves innervated by the stimulation step may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve). According to one aspect of the present invention, the measuring step is preferably accomplished via monitoring or measuring the EMG responses of the muscles innervated by the nerve(s) stimulated in step for each of the preferred functions of the present invention: surgical access, pedicle integrity assessments, and neural pathology monitoring.

The step of determining a relationship between the surgical accessory and the nerve based upon the measurement step may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions (based on any number of suitable parameters and/or characteristics). By way of example only, the step of determining a relationship, within the context of a surgical access system, may involve identifying when (and preferably the degree to which) the surgical accessory comes into close proximity with a given nerve (“nerve proximity”) and/or identifying the relative direction between the surgical accessory and the nerve (“nerve direction”). For a pedicle integrity assessment, the relationship between the surgical accessory (screw test probe) and the nerve is whether electrical communication is established therebetween. If electrical communication is established, this indicates that the medial wall of the pedicle has been cracked, stressed, or otherwise breached during the steps of hole formation and/or screw introduction. If not, this indicates that the integrity of the medial wall of the pedicle has remained intact during hole formation and/or screw introduction. This characteristic is based on the insulating properties of bone. For neural pathology assessments according to the present invention, the relationship may be, by way of example only, whether the neurophysiologic response of the nerve has changed over time. Such neurophysiologic responses may include, but are not necessarily limited to, the onset stimulation threshold for the nerve in question, the slope of the response vs. the stimulation signal for the nerve in question and/or the saturation level of the nerve in question. Changes in these parameters will indicate if the health or status of the nerve is improving or deteriorating, such as may result during surgery.

The step of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element). By way of example only, with regard to surgical access systems, this step of communicating the relationship may include, but is not necessarily limited to, visually representing the stimulation threshold of the nerve (indicating relative distance or proximity to the nerve), providing color coded graphics to indicate general proximity ranges (i.e. “green” for a range of stimulation thresholds above a predetermined safe value, “red” for range of stimulation thresholds below a predetermined unsafe value, and “yellow” for the range of stimulation thresholds in between the predetermined safe and unsafe values—designating caution), as well as providing an arrow or other suitable symbol for designating the relative direction to the nerve. This is an important feature of the present invention in that, by providing such proximity and direction information, a user will be kept informed as to whether a nerve is too close to a given surgical accessory element during and/or after the operative corridor is established to the surgical target site. This is particularly advantageous during the process of accessing the surgical target site in that it allows the user to actively avoid nerves and redirect the surgical access components to successfully create the operative corridor without impinging or otherwise compromising the nerves. Based on these nerve proximity and direction features, then, the present invention is capable of passing through virtually any tissue with minimal (if any) risk of impinging or otherwise damaging associated neural structures within the tissue, thereby making the present invention suitable for a wide variety of surgical applications.

With regard to pedicle integrity assessments, the step of communicating the relationship may include, but is not necessarily limited to, visually representing the actual stimulation threshold of an exiting nerve root alone or in combination with the stimulation threshold of a bare nerve root (with or without the difference therebetween), as well as with providing color coded graphics to indicate general ranges of pedicle integrity (i.e. “green” for a range of stimulation thresholds above a predetermined safe value—indicating “breach unlikely”, “red” for range of stimulation thresholds below a predetermined unsafe value—indicating “breach likely”, and “yellow” for the range of stimulation thresholds between the predetermined safe and unsafe values—indicating “possible breach”). This is a significant feature, and advantage over the prior art, in that it provides a straightforward and easy to interpret representation as to whether a pedicle has been breached during and/or after the process of forming the hole and/or introducing the pedicle screw. Identifying such a potential breach is helpful in that it prevents or minimizes the chance that a misplaced pedicle screw (that is, one breaching the medial wall) will be missed until after the surgery. Instead, any such misplaced pedicle screws, when stimulated according to the present invention, will produce an EMG response at a myotome level associated with the nerve in close proximity to the pedicle screw that is breaching the pedicle wall. This will indicate to the surgeon that the pedicle screw needs to be repositioned. But for this system and technique, patients may be released and subsequently experience pain due to the contact between the exiting nerve root and the pedicle screw, which oftentimes requires another costly and painful surgery.

As for neural pathology monitoring, the step of communicating the relationship may include, but is not necessarily limited to, visually representing the changes over time in the onset stimulation threshold of the nerve, the slope of the response versus the stimulation threshold of the nerve and/or the saturation level of the nerve. Once again, these changes may indicate if the health or status of the nerve is improving or deteriorating, such as may result during surgery and/or retraction. This feature is important in that it may provide qualitative feedback on the effect of the particular surgery. If it appears the health or status (pathology) of the nerve is deteriorating over time, the user may be instructed to stop or lessen the degree of retraction to avoid such deterioration. If the pathology of the nerve improves over time, it may indicate the success of the surgery in restoring or improving nerve function, such as may be the case in decompressive spinal surgery.

The present invention also encompasses a variety of techniques, algorithms, and systems for accomplishing the steps of (a) stimulating one or more electrodes provided on a surgical accessory; (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and/or communicating this relationship to the surgeon in an easy-to-interpret fashion.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a flow chart illustrating the fundamental steps of the neurophysiology-based surgical system according to the present invention;

FIG. 2 is a perspective view of an exemplary surgical system 20 capable of determining nerve proximity and direction to surgical instruments employed in accessing a surgical target site, assessing pedicle integrity before, during or after pedicle screw placement, and/or assessing the pathology (health and/or status) of a nerve or nerve root before, during, or after a surgical procedure;

FIG. 3 is a block diagram of the surgical system 20 shown in FIG. 2;

FIG. 4 is a graph illustrating a plot of a stimulation current pulse capable of producing a neuromuscular response (EMG) of the type shown in FIG. 3;

FIG. 5 is a graph illustrating a plot of the neuromuscular response (EMG) of a given myotome over time based on a current stimulation pulse (such as shown in FIG. 4) applied to a nerve bundle coupled to the given myotome;

FIG. 6 is an illustrating (graphical and schematic) of a method of automatically determining the maximum frequency (F_Max) of the stimulation current pulses according to one embodiment of the present invention;

FIG. 7 is a graph illustrating a plot of EMG response peak-to-peak voltage (V_pp) for each given stimulation current level (I_Stim) forming a stimulation current pulse according to the present invention (otherwise known as a “recruitment curve”);

FIG. 8 is a graph illustrating a traditional stimulation artifact rejection technique as may be employed in obtaining each peak-to-peak voltage (V_pp) EMG response according to the present invention;

FIG. 9 is a graph illustrating the traditional stimulation artifact rejection technique of FIG. 8, wherein a large artifact rejection causes the EMG response to become compromised;

FIG. 10 is a graph illustrating an improved stimulation artifact rejection technique according to the present invention;

FIG. 11 is a graph illustrating an improved noise artifact rejection technique according to the present invention;

FIG. 12 is a graph illustrating a plot of a neuromuscular response (EMG) over time (in response to a stimulus current pulse) showing the manner in which voltage extrema (_{VMax or Min}), (V_{Min or Max}) occur at times T1 and T2, respectively;

FIG. 13 is a graph illustrating a histogram as may be employed as part of a T1, T2 artifact rejection technique according to an alternate embodiment of the present invention;

FIGS. 14A-14E are graphs illustrating a current threshold-hunting algorithm according to one embodiment of the present invention;

FIG. 15 is a series of graphs illustrating a multi-channel current threshold-hunting algorithm according to one embodiment of the present invention;

FIGS. 16-19 are top views of a neurophysiology-based surgical access system according to one embodiment of the present invention in use accessing a surgical target site in the spine;

FIG. 20 is an exemplary screen display illustrating one embodiment of the nerve proximity or detection feature of the surgical access system of the present invention;

FIG. 21 is an exemplary screen display illustrating one embodiment of the nerve detection feature of the surgical access system of the present invention;

FIG. 22 is a graph illustrating a method of determining the direction of a nerve (denoted as an “octagon”) relative to an instrument having four (4) orthogonally disposed stimulation electrodes (denoted by the “circles”) according to one embodiment of the present invention;

FIGS. 23-24 are exemplary screen displays illustrating one embodiment of the pedicle integrity assessment feature of the present invention;

FIGS. 25-27 are exemplary screen displays illustrating another embodiment of the pedicle integrity assessment feature of the present invention;

FIG. 28 is a graph illustrating recruitment curves for a generally healthy nerve (denoted “A”) and a generally unhealthy nerve (denoted “B”) according to the nerve pathology monitoring feature of the present invention;

FIGS. 29-30 are perspective and side views, respectively, of an exemplary nerve root retractor assembly according to one embodiment of the present invention;

FIG. 31 is a perspective view of an exemplary nerve root retractor according to one embodiment of the present invention;

FIG. 32 is an exemplary screen display illustrating one embodiment of the neural pathology monitoring feature of the present invention, specifically for monitoring change in nerve function of a healthy nerve due to nerve retraction;

FIG. 33 is an exemplary screen display illustrating another embodiment of the neural pathology monitoring feature of the present invention, specifically for monitoring change in nerve function of a healthy nerve due to nerve retraction;

FIG. 34 is an exemplary screen display illustrating one embodiment of the neural pathology monitoring feature of the present invention, specifically for monitoring change in nerve function of an unhealthy nerve due to the performance of a surgical procedure; and

FIG. 35 is an exemplary screen display illustrating another embodiment of the neural pathology monitoring feature of the present invention, specifically for monitoring change in nerve function of an unhealthy nerve due to the performance of a surgical procedure.

DESCRIPTION OF THE SPECIFIC EMBODIMENTS

Illustrative embodiments of the invention are described below. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art having the benefit of this disclosure. The systems disclosed herein boast a variety of inventive features and components that warrant patent protection, both individually and in combination.

The present invention is capable of performing a variety of surgical procedures and assessments by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”). By way of example only, such surgical accessories may include, but are not necessarily limited to, any number of devices or components for creating an operative corridor to a surgical target site (such as K-wires, sequentially dilating cannula systems, distractor systems, and/or retractor systems), for retracting or otherwise protecting a nerve root before, during and/or after surgery (such as a nerve root retractor), and/or for assessing pedicle integrity (such as a pedicle screw test probe). Although described herein largely in terms of use in spinal surgery, it is to be readily appreciated that the teachings of the method and apparatus of the present invention are suitable for use in any number of additional surgical procedures wherein tissue having significant neural structures must be passed through (or near) in order to establish an operative corridor to a surgical target site, wherein neural structures are refracted, and/or wherein neural structures are located adjacent bony structures.

FIG. 1 illustrates the fundamental method steps according to the present invention, namely: (a) stimulating one or more electrodes provided on a surgical accessory; (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.

The step of stimulating may be accomplished by applying any of a variety of suitable stimulation signals to the electrode(s) on the surgical accessory, including voltage and/or current pulses of varying magnitude and/or frequency. The stimulating step may be performed at different times depending upon the particular surgical accessory in question. For example, when employed with a surgical access system, stimulation 10 may be performed during and/or after the process of creating an operative corridor to the surgical target site. When used for pedicle integrity assessments, stimulation 10 may be performed before, during and/or after the formation of the hole established to receive a pedicle screw, as well as before, during and/or after the pedicle screw is introduced into the hole. With regard to neural pathology monitoring, stimulation 10 may be performed before, during and/or after refraction of the nerve root.

The step of measuring the response of nerves innervated by the stimulation step 10 may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve). According to one aspect of the present invention, the measuring step is preferably accomplished via monitoring or measuring the EMG responses of the muscles innervated by the nerve(s) stimulated in step (a) for each of the preferred functions of the present invention: surgical access, pedicle integrity assessments, and neural pathology monitoring.

The step of determining a relationship between the surgical accessory and the nerve based upon the measurement step (b) may be performed in any number of suitable fashions depending upon the manner of measuring the response of step (b), and may define the relationship in any of a variety of fashions (based on any number of suitable parameters and/or characteristics). By way of example only, step (c) of determining a relationship, within the context of a surgical access system, may involve identifying when (and preferably the degree to which) the surgical accessory comes into close proximity with a given nerve (“nerve proximity”) and/or identifying the relative direction between the surgical accessory and the nerve (“nerve direction”). For a pedicle integrity assessment, the relationship between the surgical accessory (screw test probe) and the nerve is whether electrical communication is established therebetween. If electrical communication is established, this indicates that the medial wall of the pedicle has been cracked, stressed, or otherwise breached during the steps of hole formation and/or screw introduction. If not, this indicates that the integrity of the medial wall of the pedicle has remained intact during hole formation and/or screw introduction. This characteristic is based on the insulating properties of bone. For neural pathology assessments according to the present invention, the step (c) relationship may be, by way of example only, whether the neurophysiologic response of the nerve has changed over time. Such neurophysiologic responses may include, but are not necessarily limited to, the onset stimulation threshold for the nerve in question, the slope of the response vs. the stimulation signal for the nerve in question and/or the saturation level of the nerve in question. Changes in these parameters will indicate if the health or status of the nerve is improving or deteriorating, such as may result during surgery.

The step of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element). By way of example only, with regard to surgical access systems, step (d) of communicating the relationship may include, but is not necessarily limited to, visually representing the stimulation threshold of the nerve (indicating relative distance or proximity to the nerve), providing color coded graphics to indicate general proximity ranges (i.e. “green” for a range of stimulation thresholds above a predetermined safe value, “red” for range of stimulation thresholds below a predetermined unsafe value, and “yellow” for the range of stimulation thresholds in between the predetermined safe and unsafe values—designating caution), as well as providing an arrow or other suitable symbol for designating the relative direction to the nerve. This is an important feature of the present invention in that, by providing such proximity and direction information, a user will be kept informed as to whether a nerve is too close to a given surgical accessory element during and/or after the operative corridor is established to the surgical target site. This is particularly advantageous during the process of accessing the surgical target site in that it allows the user to actively avoid nerves and redirect the surgical access components to successfully create the operative corridor without impinging or otherwise compromising the nerves. Based on these nerve proximity and direction features, then, the present invention is capable of passing through virtually any tissue with minimal (if at all) risk of impinging or otherwise damaging associated neural structures within the tissue, thereby making the present invention suitable for a wide variety of surgical applications.

With regard to pedicle integrity assessments, step (d) of communicating the relationship may include, but is not necessarily limited to, visually representing the actual stimulation threshold of an exiting nerve root alone or in combination with the stimulation threshold of a bare nerve root (with or without the difference therebetween), as well as with providing color coded graphics to indicate general ranges of pedicle integrity (i.e. “green” for a range of stimulation thresholds above a predetermined safe value—indicating “breach unlikely”, “red” for range of stimulation thresholds below a predetermined unsafe value—indicating “breach likely”, and “yellow” for the range of stimulation thresholds between the predetermined safe and unsafe values—indicating “possible breach”). This is a significant feature, and advantage over the prior art, in that it provides a straightforward and easy to interpret representation as to whether a pedicle has been breached during and/or after the process of forming the hole and/or introducing the pedicle screw. Identifying such a potential breach is helpful in that it prevents or minimizes the chance that a misplaced pedicle screw (that is, one breaching a wall of the pedicle, such as, by way of example, the medial wall) will be missed until after the surgery. Instead, any such misplaced pedicle screws, when stimulated according to the present invention, will produce an EMG response at a myotome level associated with the nerve in close proximity to the pedicle screw that is breaching the pedicle wall. This will indicate to the surgeon that the pedicle screw needs to be repositioned. But for this system and technique, patients may be released and subsequently experience pain due to the contact between the exiting nerve root and the pedicle screw, which oftentimes requires another costly and painful surgery.

As for neural pathology monitoring, step (d) of communicating the relationship may include, but is not necessarily limited to, visually representing the changes over time in the onset stimulation threshold of the nerve, the slope of the response versus the stimulation threshold of the nerve and/or the saturation level of the nerve. Once again, these changes may indicate if the health or status of the nerve is improving or deteriorating, such as may result during surgery and/or retraction. This feature is important in that it may provide qualitative feedback on the effect of the particular surgery. If it appears the health or status (pathology) of the nerve is deteriorating over time, the user may be instructed to stop or lessen the degree of retraction to avoid such deterioration. If the pathology of the nerve improves over time, it may indicate the success of the surgery in restoring or improving nerve function, such as may be the case in decompressive spinal surgery.

FIGS. 2-3 illustrate, by way of example only, a surgical system 20 provided in accordance with a broad aspect of the present invention. The surgical system 20 includes a control unit 22, a patient module 24, an EMG harness 26 and return electrode 28 coupled to the patient module 24, and a host of surgical accessories 30 capable of being coupled to the patient module 24 via one or more accessory cables 32. In the embodiment shown, the surgical accessories 30 include (by way of example only) a sequential dilation access system 34, a pedicle testing assembly 36, and a nerve root retractor assembly 38. The control unit 22 includes a touch screen display 40 and a base 42, which collectively contain the essential processing capabilities for controlling the surgical system 20. The patient module 24 is connected to the control unit 22 via a data cable 44, which establishes the electrical connections and communications (digital and/or analog) between the control unit 22 and patient module 24. The main functions of the control unit 22 include receiving user commands via the touch screen display 40, activating stimulation in the requested mode (nerve proximity, nerve direction, screw test, and nerve pathology), processing signal data according to defined algorithms (described below), displaying received parameters and processed data, and monitoring system status and report fault conditions. The touch screen display 40 is preferably equipped with a graphical user interface (GUI) capable of communicating information to the user and receiving instructions from the user. The display 40 and/or base 42 may contain patient module interface circuitry that commands the stimulation sources, receives digitized signals and other information from the patient module 24, processes the EMG responses to extract characteristic information for each muscle group, and displays the processed data to the operator via the display 40.

As will be described in greater detail below, the surgical system 20 is capable of performing one or more of the following functions: (1) determination of nerve proximity and/or nerve direction relative to the sequential dilation access system 34 during and following the creation of an operative corridor to surgical target site; (2) assessment of pedicle integrity after hole formation and/or after pedicle screw placement via the pedicle testing assembly 36; and/or (3) assessment of nerve pathology (health or status) before, during, and/or after a surgical procedure via the nerve root retractor assembly 38. Surgical system 20 accomplishes this by having the control unit 22 and patient module 24 cooperate to send stimulation signals to one or more stimulation electrodes on the various surgical accessories 30. Depending upon the location of the surgical accessories within a patient, the stimulation signals may cause nerves adjacent to or in the general proximity of the surgical accessories 30 to innervate, which, in turn, can be monitored via the EMG harness 26. The nerve proximity and direction, pedicle integrity, and nerve pathology features of the present invention are based on assessing the evoked response of the various muscle myotomes monitored by the surgical system 20 via EMG harness 26.

The sequential dilation access system 34 comprises, by way of example only, a K-wire 46, one or more dilating cannula 48, and a working cannula 50. As will be explained in greater detail below, these components 46-50 are designed to bluntly dissect the tissue between the patient's skin and the surgical target site. In an important aspect of the present invention, the K-wire 46, dilating cannula 48 and/or working cannula 50 may be equipped with one or more stimulation electrodes to detect the presence and/or location of nerves in between the skin of the patient and the surgical target site. To facilitate this, a surgical hand-piece 52 is provided for electrically coupling the surgical accessories 46-50 to the patient module 24 (via accessory cable 32). In a preferred embodiment, the surgical hand piece 42 includes one or more buttons for selectively initiating the stimulation signal (preferably, a current signal) from the control unit 12 to a particular surgical access component 46-50. Stimulating the electrode(s) on these surgical access components 46-50 during passage through tissue in forming the operative corridor will cause nerves that come into close or relative proximity to the surgical access components 46-50 to depolarize, producing a response in the innervated myotome. By monitoring the myotomes associated with the nerves (via the EMG harness 26 and recording electrode 27) and assessing the resulting EMG responses (via the control unit 22), the sequential dilation access system 34 is capable of detecting the presence (and optionally direction to) such nerves, thereby providing the ability to actively negotiate around or past such nerves to safely and reproducibly form the operative corridor to a particular surgical target site. In one embodiment, the sequential dilation access system 34 is particularly suited for establishing an operative corridor to an intervertebral target site in a postero-lateral, trans-psoas fashion so as to avoid the bony posterior elements of the spinal column.

The pedicle testing assembly 36 includes a surgical accessory handle assembly 54 and a pedicle probe 56. The handle assembly 54 includes a cable 55 for establishing electrical communication with the patient module 24 (via the accessory cable 32). In a preferred embodiment, the pedicle probe 56 may be selectively removed from the handle assembly 54, such as by unscrewing a threaded cap 58 provided on the distal end of the handle assembly 54 (through which the proximal end of the pedicle probe 56 passes). The pedicle probe 56 includes a ball-tipped distal end 60 suitable for introduction into a pedicle hole (after hole formation but before screw insertion) and/or for placement on the head of a fully introduced pedicle screw. In both situations, the user may operate one or more buttons of the handle assembly 54 to selectively initiate a stimulation signal (preferably, a current signal) from the patient module 24 to the pedicle probe 56. With the pedicle probe 56 touching the inner wall of the pedicle hole and/or the fully introduced pedicle screw, applying a stimulation signal in this fashion serves to test the integrity of the medial wall of the pedicle. That is, a breach or compromise in the integrity of the pedicle will allow the stimulation signal to pass through the pedicle and innervate an adjacent nerve root. By monitoring the myotomes associated with the nerve roots (via the EMG harness 26 and recording electrode 27) and assessing the resulting EMG responses (via the control unit 22), the surgical system 20 can assess whether a pedicle breach occurred during hole formation and/or screw introduction. If a breach or potential breach is detected, the user may simply withdraw the misplaced pedicle screw and redirect to ensure proper placement.

The nerve root retractor assembly 38, in a preferred embodiment, comprises the same style surgical accessory handle assembly 54 as employed with in the pedicle testing assembly 36, with a selectively removable nerve root retractor 62. The nerve root retractor 62 has a generally angled orientation relative to the longitudinal axis of the handle assembly 54, and includes a curved distal end 64 having a generally arcuate nerve engagement surface 66 equipped with one or more stimulation electrodes (not shown). In use, the nerve root retractor 62 is introduced into or near a surgical target site in order to hook and retract a given nerve out of the way. According to the present invention, the nerve root may be stimulated (monopolar or bipolar) before, during, and/or after retraction in order to assess the degree to which such retraction impairs or otherwise degrades nerve function over time. To do so, the user may operate one or more buttons of the handle assembly 54 to selectively transmit a stimulation signal (preferably, a current signal) from the patient module 24 to the electrode(s) on the engagement surface 66 of the nerve root retractor 62. By monitoring the myotome associated with the nerve root being refracted (via the EMG harness 26) and assessing the resulting EMG responses (via the control unit 22), the surgical system 20 can assess whether (and the degree to which) such retraction impairs or adversely affects nerve function over time. With this information, a user may wish to periodically release the nerve root from retraction to allow nerve function to recover, thereby preventing or minimizing the risk of long-term or irreversible nerve impairment. As will be described in greater detail below, a similar neural pathology assessment can be undertaken, whereby an unhealthy nerve may be monitored to determine if nerve function improves due to a particular surgical procedure, such as spinal nerve decompression surgery.

A discussion of the algorithms and principles behind the neurophysiology for accomplishing these functions will now be undertaken, followed by a detailed description of the various implementations of these principles according to the present invention.

FIGS. 4 and 5 illustrate a fundamental aspect of the present invention: a stimulation signal (FIG. 4) and a resulting evoked response (FIG. 5). By way of example only, the stimulation signal is preferably a stimulation current signal (I_Stim) having rectangular monophasic pulses with a frequency and amplitude adjusted by system software. In a still further preferred embodiment, the stimulation current (I_Stim) may be coupled in any suitable fashion (i.e. AC or DC) and comprises rectangular monophasic pulses of 200 microsecond duration. The amplitude of the current pulses may be fixed, but will preferably sweep from current amplitudes of any suitable range, such as from 2 to 100 mA. For each nerve and myotome there is a characteristic delay from the stimulation current pulse to the EMG response (typically between 5 to 20 ms). To account for this, the frequency of the current pulses is set at a suitable level such as, in a preferred embodiment, 4 Hz to 10 Hz (and most preferably 4.5 Hz), so as to prevent stimulating the nerve before it has a chance to recover from depolarization. The EMG response shown in FIG. 5 can be characterized by a peak-to-peak voltage of V_pp=V_max−V_min.

FIG. 6 illustrates an alternate manner of setting the maximum stimulation frequency, to the extent it is desired to do so rather than simply selecting a fixed maximum stimulation frequency (such as 4.5 Hz) as described above. According to this embodiment, the maximum frequency of the stimulation pulses is automatically adjusted. After each stimulation, F_maxwill be computed as: F_max=1/(T2+T_{Safety Margin}) for the largest value of T2 from each of the active EMG channels. In one embodiment, the Safety Margin is 5 ms, although it is contemplated that this could be varied according to any number of suitable durations. Before the specified number of stimulations, the stimulations will be performed at intervals of 100-120 ms during the bracketing state, intervals of 200-240 ms during the bisection state, and intervals of 400-480 ms during the monitoring state. After the specified number of stimulations, the stimulations will be performed at the fastest interval practical (but no faster than F_max) during the bracketing state, the fastest interval practical (but no faster than Fmax/2) during the bisection state, and the fastest interval practical (but no faster than Fmax/4) during the monitoring state. The maximum frequency used until F_maxis calculated is preferably 10 Hz, although slower stimulation frequencies may be used during some acquisition algorithms. The value of F_maxused is periodically updated to ensure that it is still appropriate. For physiological reasons, the maximum frequency for stimulation will be set on a per-patient basis. Readings will be taken from all myotomes and the one with the slowest frequency (highest T2) will be recorded.

A basic premise behind the neurophysiology employed in the present invention is that each nerve has a characteristic threshold current level (I_Thresh) at which it will depolarize. Below this threshold, current stimulation will not evoke a significant EMG response (V_pp). Once the stimulation threshold (I_Thresh) is reached, the evoked response is reproducible and increases with increasing stimulation until saturation is reached. This relationship between stimulation current and EMG response may be represented graphically via a so-called “recruitment curve,” such as shown in FIG. 7, which includes an onset region, a linear region, and a saturation region. By way of example only, the present invention defines a significant EMG response to have a V_ppof approximately 100 uV. In a preferred embodiment, the lowest stimulation current that evokes this threshold voltage (V_Thresh) is called I_Thresh. As will be described in greater detail below, changes in the current threshold (I_Thresh) over time may indicate that the relative distance between the nerve and the stimulation electrode is changing (indicating nerve migration towards the surgical accessory having the stimulation electrode and/or movement of the surgical accessory towards the nerve). This is useful in performing proximity assessments between the electrode and the nerve according to an aspect of the present invention. Changes in the current threshold (I_Thresh) may also be indicative of a change in the degree of electrical communication between a stimulation electrode and a nerve. This may be helpful, by way of example, in assessing if a screw or similar instrument has inadvertently breached the medial wall of a pedicle. More specifically, where an initial determination of (I_Thresh), such as by applying a stimulation current to the interior of a hole created to receive a pedicle screw, is greater than a later determination of (I_Thresh), such as by applying a stimulation current to the tip of the pedicle screw after insertion, the decrease in I_Thresh, if large enough, may indicate electrical communication between the pedicle screw and the nerve. Based on the insulation properties of bone, such electrical communication would indicate a breach of the pedicle. As will also be in greater detail below, changes in the current threshold (I_Thresh), the slope of the linear region, and the saturation level over time are indicative of changes in the pathology (that is, health or status) of a given nerve. This is useful in assessing the effects of surgery on an unhealthy nerve (such as decompression surgery) as well as assessing the effects of nerve retraction on a healthy nerve (so as to prevent or minimize the risk of damage due to retraction).

In order to obtain this useful information, the present invention must first identify the peak-to-peak voltage (V_pp) of each EMG response corresponding a given stimulation current (I_Stim). The existence stimulation and/or noise artifacts, however, can conspire to create an erroneous V_ppmeasurement of the electrically evoked EMG response. To overcome this challenge, the surgical system 20 of the present invention may employ any number of suitable artifact rejection techniques, including the traditional stimulation artifact rejection technique shown in FIG. 8. Under this technique, stimulation artifact rejection is undertaken by providing a simple artifact rejection window T1_WINat the beginning of the EMG waveform. During this T₁window, the EMG waveform is ignored and V_ppis calculated based on the max and min values outside this window. (T1 is the time of the first extremum (min or max) and T2 is the time of the second extremum.) In one embodiment, the artifact rejection window T1_WINmay be set to about 7.3 msec. While generally suitable, there are situations where this stimulation artifact rejection technique of FIG. 8 is not optimum, such as in the presence of a large stimulation artifact (see FIG. 9). The presence of a large stimulation artifact causes the stimulation artifact to cross over the window T1_WINand blend in with the EMG. Making the stimulation artifact window larger is not effective, since there is no clear separation between EMG and stimulation artifact.

FIG. 10 illustrates a stimulation artifact rejection technique according to the present invention, which solves the above-identified problem with traditional stimulation artifact rejection. Under this technique, a T1 validation window (T1-V_WIN) is defined immediately following the T1 window (T1_WIN). If the determined V_ppexceeds the threshold for recruiting, but T1 falls within this T1 validation window, then the stimulation artifact is considered to be substantial and the EMG is considered to have not recruited. An operator may be alerted, based on the substantial nature of the stimulation artifact. This method of stimulation artifact rejection is thus able to identify situations where the stimulation artifact is large enough to cause the V_ppto exceed the recruit threshold. To account for noise, the T1 validation window (T1-V_WIN) should be within the range of 0.1 ms to 1 ms wide (preferably about 0.5 ms). The T1 validation window (T1-V_WIN) should not be so large that the T1 from an actual EMG waveform could fall within.

FIG. 11 illustrates a noise artifact rejection technique according to the present invention. When noise artifacts fall in the time window where an EMG response is expected, their presence can be difficult to identify. Artifacts outside the expected response window, however, are relatively easy to identify. The present invention capitalizes on this and defines a T2 validation window (T2-V_WIN) analogous to the T₁validation window (T1-V_WIN) described above with reference to FIG. 10. As shown, T2 must occur prior to a defined limit, which, according to one embodiment of the present invention, may be set having a range of between 40 ms to 50 ms (preferably about 47 ms). If the V_ppof the EMG response exceeds the threshold for recruiting, but T2 falls beyond the T2 validation window (T2-V_WIN), then the noise artifact is considered to be substantial and the EMG is considered to have not recruited. An operator may be alerted, based on the substantial nature of the noise artifact.

FIG. 12 illustrates a still further manner of performing stimulation artifact rejection according to an alternate embodiment of the present invention. This artifact rejection is premised on the characteristic delay from the stimulation current pulse to the EMG response. For each stimulation current pulse, the time from the current pulse to the first extremum (max or min) is T₁and to the second extremum (max or min) is T₂. As will be described below, the values of T₁, T₂are each compiled into a histogram period (see FIG. 13). New values of T₁, T₂are acquired for each stimulation and the histograms are continuously updated. The value of T₁, and T₂used is the center value of the largest bin in the histogram. The values of T₁, T₂are continuously updated as the histograms change. Initially V_ppis acquired using a window that contains the entire EMG response. After 20 samples, the use of T₁, T₂windows is phased in over a period of 200 samples. V_maxand V_minare then acquired only during windows centered around T₁, T₂with widths of, by way of example only, 5 msec. This method of acquiring V_ppautomatically rejects the artifact if T₁, T₂fall outside of their respective windows.

Having measured each V_ppEMG response (as facilitated by the stimulation and/or noise artifact rejection techniques described above), this V_ppinformation is then analyzed relative to the stimulation current in order to determine a relationship between the nerve and the given surgical accessory transmitting the stimulation current. More specifically, the present invention determines these relationships (between nerve and surgical accessory) by identifying the minimum stimulation current (I_Thresh) capable of resulting in a predetermined V_ppEMG response. According to the present invention, the determination of I_Threshmay be accomplished via any of a variety of suitable algorithms or techniques.

FIGS. 14A-14E illustrate, by way of example only, a threshold-hunting algorithm for quickly finding the threshold current (I_Thresh) for each nerve being stimulated by a given stimulation current (I_Stim). Threshold current (I_Thresh), once again, is the minimum stimulation current (I_Stim) that results in a V_ppthat is greater than a known threshold voltage (V_Thresh). The value of is adjusted by a bracketing method as follows. The first bracket is 0.2 mA and 0.3 mA. If the V_ppcorresponding to both of these stimulation currents is lower than V_Thresh, then the bracket size is doubled to 0.2 mA and 0.4 mA. This doubling of the bracket size continues until the upper end of the bracket results in a V_ppthat is above V_Thresh. The size of the brackets is then reduced by a bisection method. A current stimulation value at the midpoint of the bracket is used and if this results in a V_ppthat is above V_Thresh, then the lower half becomes the new bracket. Likewise, if the midpoint V_ppis below V_Threshthen the upper half becomes the new bracket. This bisection method is used until the bracket size has been reduced to I_ThreshmA. I_Threshmay be selected as a value falling within the bracket, but is preferably defined as the midpoint of the bracket.

The threshold-hunting algorithm of this embodiment will support three states: bracketing, bisection, and monitoring. A stimulation current bracket is a range of stimulation currents that bracket the stimulation current threshold I_Thresh. The width of a bracket is the upper boundary value minus the lower boundary value. If the stimulation current threshold I_Threshof a channel exceeds the maximum stimulation current, that threshold is considered out-of-range. During the bracketing state, threshold hunting will employ the method below to select stimulation currents and identify stimulation current brackets for each EMG channel in range.

The method for finding the minimum stimulation current uses the methods of bracketing and bisection. The “root” is identified for a function that has the value−1 for stimulation currents that do not evoke adequate response; the function has the value+1 for stimulation currents that evoke a response. The root occurs when the function jumps from −1 to +1 as stimulation current is increased: the function never has the value of precisely zero. The root will not be known exactly, but only with a level of precision related to the minimum bracket width. The root is found by identifying a range that must contain the root. The upper bound of this range is the lowest stimulation current I_Threshwhere the function returns the value+1, i.e. the minimum stimulation current that evokes response. The lower bound of this range is the highest stimulation current I_Threshwhere the function returns the value−1, i.e. the maximum stimulation current that does not evoke a response.

The proximity function begins by adjusting the stimulation current until the root is bracketed (FIG. 14B). The initial bracketing range may be provided in any number of suitable ranges. In one embodiment, the initial bracketing range is 0.2 to 0.3 mA. If the upper stimulation current does not evoke a response, the upper end of the range should be increased. The range scale factor is 2. The stimulation current should preferably not be increased by more than 10 mA in one iteration. The stimulation current should preferably never exceed the programmed maximum stimulation current. For each stimulation, the algorithm will examine the response of each active channel to determine whether it falls within that bracket. Once the stimulation current threshold of each channel has been bracketed, the algorithm transitions to the bisection state.

During the bisection state (FIGS. 14C and 14D), threshold hunting will employ the method described below to select stimulation currents and narrow the bracket to a selected width (for example, 0.1 mA) for each EMG channel with an in-range threshold. After the minimum stimulation current has been bracketed (FIG. 14B), the range containing the root is refined until the root is known with a specified accuracy. The bisection method is used to refine the range containing the root. In one embodiment, the root should be found to a precision of 0.1 mA. During the bisection method, the stimulation current at the midpoint of the bracket is used. If the stimulation evokes a response, the bracket shrinks to the lower half of the previous range. If the stimulation fails to evoke a response, the bracket shrinks to the upper half of the previous range. The proximity algorithm is locked on the electrode position when the response threshold is bracketed by stimulation currents separated by the selected width (i.e. 0.1 mA). The process is repeated for each of the active channels until all thresholds are precisely known. At that time, the algorithm enters the monitoring state.

During the monitoring state (FIG. 14E), threshold hunting will employ the method described below to select stimulation currents and identify whether stimulation current thresholds are changing. In the monitoring state, the stimulation current level is decremented or incremented by 0.1 mA, depending on the response of a specific channel. If the threshold has not changed then the lower end of the bracket should not evoke a response, while the upper end of the bracket should. If either of these conditions fail, the bracket is adjusted accordingly. The process is repeated for each of the active channels to continue to assure that each threshold is bracketed. If stimulations fail to evoke the expected response three times in a row, then the algorithm may transition back to the bracketing state in order to reestablish the bracket.

When it is necessary to determine the stimulation current thresholds (I_Thresh) for more than one channel, they will be obtained by time-multiplexing the threshold-hunting algorithm as shown in FIG. 15. During the bracketing state, the algorithm will start with a stimulation current bracket of 0.2 mA and increase the size of the bracket. With each bracket, the algorithm will measure the V_ppof all channels to determine which bracket they fall into. After this first pass, the algorithm will determine which bracket contains the I_Thresh, for each channel. Next, during the bisection state, the algorithm will start with the lowest bracket that contains an I_Threshand bisect it until I_Threshis found within 0.1 mA. If there are more than one I_Threshwithin a bracket, they will be separated out during the bisection process, and the one with the lowest value will be found first. During the monitoring state, the algorithm will monitor the upper and lower boundaries of the brackets for each I_Thresh, starting with the lowest. If the I_Threshfor one or more channels is not found in it's bracket, then the algorithm goes back to the bracketing state to reestablish the bracket for those channels.

A still further manner of performing multi-channel threshold hunting is described as follows, with reference to FIGS. 14-15. This technique monitors multiple channels but reports the result for a single channel. The user chooses one of two channel selection modes: auto or manual. In the manual channel selection mode, the system will track the stimulation threshold I_Threshfor a single EMG channel, as shown in FIG. 14. In the auto channel selection mode, the system will monitor responses on a set of channels and track to the lowest responding channel. The auto mode permits the user to select the set of channels to track. Individual channels can be added or subtracted from the set at any time. Tracking to the lowest responding channel is performed in this fashion. First, after stimulation, if no channels in the selected set respond, then the stimulation current is below the lowest responding channel. If any channels respond, then the stimulation current is above the lowest responding channel. Coupling this logic with the bracketing, bisection, and monitoring technique described above allows the system to track to the lowest responding channel, and do so in a quick and accurate fashion.

If during monitoring, the tracked channel falls out of the bracket, or if any channel responds at the low end of the bracket, then the bracket will be expanded again, as before, until the lowest responding channel is bracketed again. However, unlike the embodiments shown in FIGS. 14 and 15, the bracket is expanded in situ rather than beginning again from the start. For example, a bracket of 4.5 to 4.6 mA that fails to recruit at both levels is expanded to higher currents. First, the bracket width is doubled from 0.1 mA to 0.2 mA, resulting in stimulation current at 4.7 mA. If this fails to recruit, the bracket is again doubled to 0.4 mA, with stimulation current at 4.9 mA. The pattern continues with stimulations at 5.3, 6.1, and 9.3 mA, corresponding to bracket sizes of 0.8, 1.6, and 3.2 mA, until the threshold is bracketed. If a response is evoked at both ends of the original bracket, the same bracket-doubling technique is used moving toward lower stimulation currents.

The reason for doubling the bracket size each time is to identify the threshold current with as few stimulations as practical. The reason for starting the bracket doubling in situ rather than starting over from zero is twofold: (1) to take advantage of threshold information that is already known, and (2) it is more likely that the current threshold has not moved far from where it was previously bracketed. The advantage of tracking only to the lowest channel is that it provides the most relevant nerve proximity information with fewer stimulation pulses than multi-channel detection as with that shown in FIG. 15. This is an advantage because fewer stimulation pulses means a faster responding system, with the goal being to be able to track movement of the stimulation electrode in real time.

After identifying the threshold current I_Thresh, this information may be employed to determine any of a variety of relationships between the surgical accessory and the nerve. For example, as will be described in greater detail below, determining the current threshold I_Threshof a nerve while using a surgical access system (such as the sequential dilation system 34 of FIG. 2) may involve determining when (and preferably the degree to which) the surgical accessory comes into close proximity with a given nerve (“nerve proximity”) and/or identifying the relative direction between the surgical accessory and the nerve (“nerve direction”). For a pedicle integrity assessment, the relationship between the pedicle testing assembly 36 and the nerve is whether electrical communication is established therebetween. If electrical communication is established, this indicates that the medial wall of the pedicle has been cracked, stressed, or otherwise breached during the steps of hole formation and/or screw introduction. If not, this indicates that the integrity of the medial wall of the pedicle has remained intact during hole formation and/or screw introduction. This characteristic is based on the insulating properties of bone. For neural pathology assessments according to the present invention, the relationship may be, by way of example only, whether the neurophysiologic response of the nerve has changed over time. Such neurophysiologic responses may include, but are not necessarily limited to, the onset stimulation threshold for the nerve in question, the slope of the response vs. the stimulation signal for the nerve in question and/or the saturation level of the nerve in question. Changes in these parameters will indicate if the health or status of the nerve is improving or deteriorating, such as may result during surgery or nerve retraction.

In a significant aspect of the present invention, the relationships determined above based on the current threshold determination may be communicated to the user in an easy to use format, including but not limited to, alpha-numeric and/or graphical information regarding mode of operation, nerve proximity, nerve direction, nerve pathology, pedicle integrity assessments, stimulation level, EMG responses, advance or hold instructions, instrument in use, set-up, and related instructions for the user. This advantageously provides the ability to present simplified yet meaningful data to the user, as opposed to the actual EMG waveforms that are displayed to the users in traditional EMG systems. Due to the complexity in interpreting EMG waveforms, such prior art systems typically require an additional person specifically trained in such matters which, in turn, can be disadvantageous in that it translates into extra expense (having yet another highly trained person in attendance) and oftentimes presents scheduling challenges because most hospitals do not retain such personnel.

Having described the fundamental aspects of the neurophysiology principles and algorithms of the present invention, various implementations according to the present invention will now be described.

I. Surgical Access: Nerve Proximity and Direction

FIGS. 2-3 illustrate an exemplary embodiment of the surgical system 20 of the present invention, including the sequential dilation access system 34. The sequential dilation access system 34 of the present invention is capable of accomplishing safe and reproducible access to a surgical target site. It does so by detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor through (or near) any of a variety of tissues having such neural structures, which, if contacted or impinged, may otherwise result in neural impairment for the patient. The surgical system 20 does so by electrically stimulating nerves via one or more stimulation electrodes at the distal end of the surgical access components 46-50 while monitoring the EMG responses of the muscle groups innervated by the nerves.

In one embodiment, the surgical system 20 accomplishes this through the use of the surgical hand-piece 52, which may be electrically coupled to the K-wire 46 via a first cable connector 51a, 51b and to either the dilating cannula 48 or the working cannula 50 via a second cable connector 53a, 53b. For the K-wire 46 and working cannula 50, cables are directly connected between these accessories and the respective cable connectors 51a, 53a for establishing electrical connection to the stimulation electrode(s). In one embodiment, a pincher or clamp-type device 57 is provided to selectively establish electrical communication between the surgical hand-piece 52 and the stimulation electrode(s) on the distal end of the cannula 48. This is accomplished by providing electrical contacts on the inner surface of the opposing arms forming the clamp-type device 57, wherein the contacts are dimensioned to be engaged with electrical contacts (preferably in a male-female engagement scenario) provided on the dilating cannula 48 and working cannula 50. The surgical hand-piece 52 includes one or more buttons such that a user may selectively direct a stimulation current signal from the control unit 22 to the electrode(s) on the distal ends of the surgical access components 46-50. In an important aspect, each surgical access component 46-50 is insulated along its entire length, with the exception of the electrode(s) at their distal end (and, in the case of the dilating cannula 48 and working cannula 50, the electrical contacts at their proximal ends for engagement with the clamp 57). The EMG responses corresponding to such stimulation may be monitored and assessed according to the present invention in order to provide nerve proximity and/or nerve direction information to the user.

When employed in spinal procedures, for example, such EMG monitoring would preferably be accomplished by connecting the EMG harness 26 to the myotomes in the patient's legs corresponding to the exiting nerve roots associated with the particular spinal operation level. In a preferred embodiment, this is accomplished via 8 pairs of EMG electrodes 27 placed on the skin over the major muscle groups on the legs (four per side), an anode electrode 29 providing a return path for the stimulation current, and a common electrode 31 providing a ground reference to pre-amplifiers in the patient module 24. Although not shown, it will be appreciated that any of a variety of electrodes can be employed, including but not limited to needle electrodes. The EMG responses measured via the EMG harness 26 provide a quantitative measure of the nerve depolarization caused by the electrical stimulus. By way of example, the placement of EMG electrodes 27 may be undertaken according to the manner shown in Table 1 below for spinal surgery:

TABLE 1

Color
Channel ID
Myotome
Spinal Level

Blue
Right 1
Right Vastus Medialis
L2, L3, L4

Violet
Right 2
Right Tibialis Anterior
L4, L5

Grey
Right 3
Right Biceps Femoris
L5, S1, S2

White
Right 4
Right Gastroc. Medial
S1, S2

Red
Left 1
Left Vastus Medialis
L2, L3, L4

Orange
Left 2
Left Tibialis Anterior
L4, L5

Yellow
Left 3
Left Biceps Femoris
L5, S1, S2

Green
Left 4
Left Gastroc. Medial
S1, S2

FIGS. 16-19 illustrate the sequential dilation access system 34 of the present invention in use creating an operative corridor to an intervertebral disk. As shown in FIG. 16, an initial dilating cannula 48 is advanced towards the target site with the K-wire 46 disposed within an inner lumen within the dilating cannula 48. This may be facilitated by first aligning the K-wire 46 and initial dilating cannula 48 using any number of commercially available surgical guide frames. In one embodiment, as best shown in the expanded insets A and B, the K-wire 46 and initial dilating cannula 48 are each equipped with a single stimulation electrode 70 to detect the presence and/or location of nerves in between the skin of the patient and the surgical target site. More specifically, each electrode 70 is positioned at an angle relative to the longitudinal axis of the K-wire 46 and dilator 48 (and working cannula 50). In one embodiment, this angle may range from 5 to 85 degrees from the longitudinal axis of these surgical access components 46-50. By providing each stimulation electrode 70 in this fashion, the stimulation current will be directed angularly from the distal tip of the respective accessory 46, 48. This electrode configuration is advantageous in determining proximity, as well as direction, according to the present invention in that a user may simply rotate the K-wire 46 and/or dilating cannula 48 while stimulating the electrode 70. This may be done continuously or step-wise, and preferably while in a fixed axial position. In either case, the user will be able to determine the location of nerves by viewing the proximity information on the display screen 40 and observing changes as the electrode 70 is rotated. This may be facilitated by placing a reference mark (not shown) on the K-wire 46 and/or dilator 48 (or a control element coupled thereto), indicating the orientation of the electrode 70 to the user.

In the embodiment shown, the trajectory of the K-wire 46 and initial dilator 48 is such that they progress towards an intervertebral target site in a postero-lateral, trans-psoas fashion so as to avoid the bony posterior elements of the spinal column. Once the K-wire 46 is docked against the annulus of the particular intervertebral disk, cannulae of increasing diameter may then be guided over the previously installed cannula 48 until a desired lumen diameter is installed, as shown in FIG. 17. By way of example only, the dilating cannulae 26 may range in diameter from 6 mm to 30 mm, with length generally decreasing with increasing diameter size. Depth indicia 72 may be optionally provided along the length of each dilating cannula 48 to aid the user in gauging the depth between the skin of the patient and the surgical target site. As shown in FIG. 18, the working cannula 50 may be slideably advanced over the last dilating cannula 48 after a desired level of tissue dilation has been achieved. As shown in FIG. 19, the last dilating cannula 48 and then all the dilating cannulae 26 may then be removed from inside the inner lumen of the working cannula 50 to establish the operative corridor therethrough.

During the advancement of the K-wire 46, each dilating cannula 48, and the working cannula 50, the surgical system 20 will perform (under the direction of a user) the nerve proximity and optionally nerve direction assessments according to the present invention. By way of example, this may be explained with reference to FIGS. 20 and 21, which illustrate exemplary graphic user interface (GUI) screens provided on the screen display 40 for the purpose of allowing the user to control the surgical system 20 to access a surgical target site according to the present invention. In one embodiment, the surgical system 20 initially operates in a “DETECTION” mode, as shown in FIG. 20, wherein a mode label 80 will preferably show the word “DETECTION” highlighted to denote the nerve proximity function of the present invention. A spine image 81 will preferably be provided showing electrode placement on the body, with labeled EMG channel number tabs 82 on each side (1-4 on left and right) capable of being highlighted or colored depending on the specific function being performed. A myotome label 83 is provided indicating the myotome associated with each EMG channel tab 81, including (optionally) the corresponding spinal level(s) associated with the channel of interest. A surgical accessory label 84 is provided indicating the particular surgical accessory 30 being employed at any given time (i.e. “Dilating Cannula” to denote use of the sequential dilation access system 34), as well as a “Dilator in Use” display 85 showing (graphically and numerically) the particular diameter of the dilating cannula 48 in use. A threshold label 86 is also provided indicating the stimulation threshold required to elicit a measurable EMG response for a given myotome. In one embodiment, this is situated, by way of example only, within a cannula graphic 87 denoting a cross-section of the dilating cannula in use). A horizontal bar-chart 88 may also be provided indicating the stimulation level being emitted from the particular surgical accessory in use.

Any number of the above-identified indicia (such as the threshold label 86 and EMG channel tabs 82) may be color-coded to indicate general proximity ranges (i.e. “green” for a range of stimulation thresholds above a predetermined safe value, “red” for range of stimulation thresholds below a predetermined unsafe value, and “yellow” for the range of stimulation thresholds in between the predetermined safe and unsafe values—designating caution). In one embodiment, “green” denotes a stimulation threshold range of 9 milliamps (mA) or greater, “yellow” denotes a stimulation threshold range of 6-8 mA, and “red” denotes a stimulation threshold range of 6 mA or below. An “Advance-or-Hold” display 89 may also be provided to aid the user in progressing safely through the tissue required to create the operative corridor. ADVANCE may be highlighted indicating it is safe to advance the cannula (such as where the stimulation threshold is within the safe or “green” range). HOLD may be highlighted indicating to the user that the particular surgical accessory may be too close to a nerve (such as where the stimulation threshold is within the “yellow” or “red” ranges) and/or that the surgical system 20 is in the process of determining proximity and/or direction. In one embodiment, ADVANCE may be omitted, leaving it to the discretion of the user to advance the dilating cannula as soon as the HOLD is no longer illuminated or highlighted.

Insertion and advancement of the access instruments 46-50 should be performed at a rate sufficiently slow to allow the surgical system 20 to provide real-time indication of the presence of nerves that may lie in the path of the tip. To facilitate this, the threshold current I_Threshmay be displayed such that it will indicate when the computation is finished and the data is accurate. For example, when the DETECTION information is up to date and the instrument such that it is now ready to be advanced by the surgeon, it is contemplated to have the color display show up as saturated to communicate this fact to the surgeon. During advancement of the instrument, if an EMG channel's color range changes from green to yellow, advancement should proceed more slowly, with careful observation of the detection level. If the channel color stays yellow or turns green after further advancement, it is a possible indication that the instrument tip has passed, and is moving farther away from the nerve. If after further advancement, however, the channel color turns red, then it is a possible indication that the instrument tip has moved closer to a nerve. At this point the display will show the value of the stimulation current threshold in mA. Further advancement should be attempted only with extreme caution, while observing the threshold values, and only if the clinician deems it safe. If the clinician decides to advance the instrument tip further, an increase in threshold value (e.g. from 3 mA to 4 mA) may indicate the Instrument tip has safely passed the nerve. It may also be an indication that the instrument tip has encountered and is compressing the nerve. The latter may be detected by listening for sporadic outbursts, or “pops”, of nerve activity on a free running EMG audio output forming part of the surgical system 20.

Once a nerve is detected using the K-wire 46, dilating cannula 48, or the working cannula 50, the surgeon may select the DIRECTION function to determine the angular direction to the nerve relative to a reference mark on the access components 46-50, as shown in FIG. 21. In one embodiment, a directional arrow 90 is provided, by way of example only, disposed around the cannula graphic 87 for the purpose of graphically indicating to the user what direction the nerve is relative to the access components 46-50. This information helps the surgeon avoid the nerve as he or she advances the cannula. In one embodiment, this directional capability is accomplished by equipping the dilators 48 and working cannula 50 with four (4) stimulation electrodes disposed orthogonally on their distal tip. These electrodes are preferably scanned in a monopolar configuration (that is, using each of the 4 electrodes as the stimulation source). The threshold current (I_Thresh) is found for each of the electrodes by measuring the muscle evoked potential response V_ppand comparing it to a known threshold V_thresh. From this information, the direction from a stimulation electrode to a nerve may be determined according to the algorithm and technique set forth below and with immediate reference to FIG. 22. The four (4) electrodes are placed on the x and y axes of a two dimensional coordinate system at radius R from the origin. A vector is drawn from the origin along the axis corresponding to each electrode that has a length equal to I_Threshfor that electrode. The vector from the origin to a direction pointing toward the nerve is then computed. Using the geometry shown, the (x,y) coordinates of the nerve, taken as a single point, can be determined as a function of the distance from the nerve to each of four electrodes. This can be expressly mathematically as follows:

Where the “circles” denote the position of the electrode respective to the origin or center of the cannula and the “octagon” denotes the position of a nerve, and d₁, d₂, d₃, and d₄denote the distance between the nerve and electrodes 1-4 respectively, it can be shown that:

$x = \frac{d_{1}^{2} - d_{3}^{2}}{- 4 R} and y = \frac{d_{2}^{2} - d_{4}^{2}}{- 4 R}$

- Where R is the cannula radius, standardized to 1, since angles and not absolute values are measured.

After conversion from (x,y) to polar coordinates (r,θ), then θ is the angular direction to the nerve. This angular direction may then be displayed to the user, by way of example only, as the arrow 91 shown in FIG. 21 pointing towards the nerve. In this fashion, the surgeon can actively avoid the nerve, thereby increasing patient safety while accessing the surgical target site. The surgeon may select any one of the 4 channels available to perform the Direction Function. The surgeon should preferably not move or rotate the instrument while using the Direction Function, but rather should return to the Detection Function to continue advancing the instrument.

After establishing an operative corridor to a surgical target site via the surgical access system 34 of the present invention, any number of suitable instruments and/or implants may be introduced into the surgical target site depending upon the particular type of surgery and surgical need. By way of example only, in spinal applications, any number of implants and/or instruments may be introduced through the working cannula 50, including but not limited to spinal fusion constructs (such as allograft implants, ceramic implants, cages, mesh, etc . . . ), fixation devices (such as pedicle and/or facet screws and related tension bands or rod systems), and any number of motion-preserving devices (including but not limited to total disc replacement systems).

II. Pedicle Integrity Assessment

With reference again to FIGS. 2-3, the surgical system 20 can also be employed to perform pedicle integrity assessments via the use of pedicle testing assembly 36. More specifically, The pedicle testing assembly 36 of the present invention is used to test the integrity of pedicle holes (after formation) and/or screws (after introduction). The pedicle testing assembly 36 includes a handle assembly 54 and a probe member 56 having a generally ball-tipped end 60. The handle 54 may be equipped with a mechanism (via hardware and/or software) to identify itself to the surgical system 20 when it is attached. In one embodiment, the probe member 56 is disposable and the handle 54 is reusable and sterilizable. The handle 54 may be equipped with one or more buttons for selectively applying the electrical stimulation to the ball-tipped end 60 at the end of the probe member 56. In use, the ball tip 60 of the probe member 56 is placed in the screw hole prior to screw insertion or placed on the installed screw head and then stimulated to initiate the pedicle integrity assessment function of the present invention. As will be explained in greater detail below, it may also applied directly to a nerve to obtain a baseline current threshold level before testing either the screw hole or screw. If the pedicle wall has been breached by the screw or tap or other device employed to form the screw hole, the stimulation current will pass through the bone to the adjacent nerve roots such that they will depolarize at a lower stimulation current.

Upon pressing the button on the screw test handle 54, the software will execute a testing algorithm to apply a stimulation current to the particular target (i.e. screw hole, inserted pedicle screw, or bare nerve), setting in motion the pedicle integrity assessment function of the present invention. The pedicle integrity assessment features of the present invention may include, by way of example only, an “Actual” mode (FIGS. 23-24) for displaying the actual stimulation threshold 91 measured for a given myotome, as well as a “Relative” mode (FIGS. 25-27) for displaying the difference 92 between a baseline stimulation threshold assessment 93 of a bare nerve root and an actual stimulation threshold assessment 91 for a given myotome. In either case, the surgical accessory label 84 displays the word “SCREW TEST” to denote use of the pedicle testing assembly 36 for performing pedicle integrity assessments. The screw test algorithm according to the present invention preferably determines the depolarization (threshold) current for all responding EMG channels. In one embodiment, the EMG channel tabs 82 may be configured such that the EMG channel having the lowest stimulation threshold will be automatically enlarged and/or highlighted and/or colored (EMG channel tab R3 as shown in FIG. 23) to clearly indicate this fact to the user. As shown in FIG. 24, this feature may be overridden by manually selecting another EMG channel tab (such as EMG channel tab R1 in FIG. 24) by touching the particular EMG channel tab 82 on the touch screen display 40. In this instance, a warning symbol 94 may be provided next to the EMG channel tab having the lowest stimulation threshold (once again, EMG channel tab R3 in FIG. 23) to inform the user that the stimulation threshold 91 is not the lowest stimulation threshold.

Any number of the above-identified indicia (such as the baseline stimulation 93, actual stimulation 91, difference 92, and EMG channel tabs 82) may be color-coded to indicate general safety ranges (i.e. “green” for a range of stimulation thresholds above a predetermined safe value, “red” for range of stimulation thresholds below a predetermined unsafe value, and “yellow” for the range of stimulation thresholds in between the predetermined safe and unsafe values—designating caution). In one embodiment, “green” denotes a stimulation threshold range of 9 milliamps (mA) or greater, “yellow” denotes a stimulation threshold range of 6-8 mA, and “red” denotes a stimulation threshold range of 6 mA or below. By providing this information graphically, a surgeon may quickly and easily test to determine if the integrity of a pedicle has been breached or otherwise compromised, such as may result due to the formation of a pedicle screw hole and/or introduction of a pedicle screw. More specifically, if after stimulating the screw hole and/or pedicle screw itself the stimulation threshold is: (a) at or below 6 mA, the threshold display 40 will illuminate “red” and thus indicate to the surgeon that a breach is likely; (b) between 6 and 8 mA, the threshold display 40 will illuminate “yellow” and thus indicate to the surgeon that a breach is possible; and/or (c) at or above 8 mA, the threshold display 40 will illuminate “green” and thus indicate to the surgeon that a breach is unlikely. If a breach is possible or likely (that is, “yellow” or “red”), the surgeon may choose to withdraw the pedicle screw and redirect it along a different trajectory to ensure the pedicle screw no longer breaches (or comes close to breaching) the medial wall of the pedicle.

III. Neural Pathology Monitoring

The surgical system 20 may also be employed to perform neural pathology monitoring. As used herein, “neural pathology monitoring” is defined to include monitoring the effect of nerve retraction over time (“nerve retraction monitoring”), as well as monitoring the effect of a surgery on a particular unhealthy nerve (“surgical effect monitoring”). The former—nerve retraction monitoring—is advantageous in that it informs the surgeon if, and the extent to which, such refraction is degrading or damaging an otherwise healthy nerve under retraction. The latter—surgical effect monitoring—is advantageous in that it informs the surgeon if, and the extent to which, the given surgical procedure is improving or aiding a previously unhealthy nerve. In both cases, the qualitative assessment of improvement or degradation of nerve function may be defined, by way of example, based on one or more of the stimulation threshold (I_Thresh), the slope of the EMG response (uV) versus the corresponding stimulation threshold (I_Thresh), and/or the saturation or maximum EMG response (V_pp) for a given nerve root being monitored.

FIG. 28 illustrates this important aspect of the present invention, noting the differences between a healthy nerve (A) and an unhealthy nerve (B). The inventors have found through experimentation that information regarding nerve pathology (or “health” or “status”) can be extracted from recruitment curves generated according to the present invention. In particular, it has been found that a healthy nerve or nerve bundle will produce a recruitment curve having a generally low current threshold (I_Thresh), a linear region having a relatively steep slope, and a relatively high saturation region (similar to those shown on recruitment curve “A” in FIG. 28). On the contrary, a nerve or nerve bundle that is unhealthy or whose function is otherwise compromised or impaired (such as being impinged by spinal structures or by prolonged retraction) will produce recruitment curve having a generally higher threshold, a linear region of reduced slope, and a relatively low saturation region (similar to those shown on recruitment curve “B” in FIG. 28). By recognizing these characteristics, one can monitor a nerve root being retracted during a procedure to determine if its pathology or health is affected (i.e. negatively) by such retraction. Moreover, one can monitor a nerve root that has already been deemed pathologic or unhealthy before the procedure (such as may be caused by being impinged by bony structures or a bulging annulus) to determine if its pathology or health is affected (i.e. positively) by the procedure.

The nerve root retractor assembly 38 shown in FIG. 2 is capable of performing both types of neural pathology monitoring. However, based on its particular shape and configuration (being bent and suitably shaped to hook and thereafter move a nerve root out of a surgical target site), it is better suited to perform “nerve retraction monitoring.” With combined reference to FIGS. 2 and 29-31, the nerve root retractor assembly 38 includes the same style surgical accessory handle assembly 54 as employed with in the pedicle testing assembly 36. The nerve root retractor 62 has a generally angled orientation relative to the longitudinal axis of the handle assembly 54. The distal end 64 is generally curved and includes an arcuate nerve engagement surface 66 equipped with, by way of example only, two stimulation electrodes 100. As best shown in FIG. 31, the nerve root retractor 62 is preferably removable from the handle assembly 36. To accomplish this, the handle assembly 54 includes a detachable cap member 102. Threads 104 are provided on the proximal end of the nerve root refractor 62 to allow a threaded coupling engagement between the handle assembly 54 and the nerve root retractor 62. During such engagement, electrical contacts 106 on the nerve root refractor 62 becomes electrically coupled to the handle assembly 54 such that, upon activation of one or more of the buttons 108, 110, a stimulation current signal will be transmitted from the control unit 22 and/or patient module 24 and delivered to the stimulation electrodes 100 on the nerve root retractor 62 for the purpose of performing neural pathology monitoring according to the present invention. The nerve root retractor 62 is preferably disposable and, as described above, the handle assembly 54 is reusable and sterilizable.

In use, the nerve root retractor 62 is introduced into or near a surgical target site in order to hook and retract a given nerve out of the way. According to the present invention, the nerve root may be stimulated (monopolar or bipolar) before, during, and/or after retraction in order to assess the degree to which such retraction impairs or otherwise degrades nerve function over time. To do so, the user may operate one or more buttons 108, 110 of the handle assembly 54 to selectively transmit a stimulation signal (preferably, a current signal) from the patient module 24 to the electrode(s) on the engagement surface 66 of the nerve root retractor 62. By monitoring the myotome associated with the nerve root being retracted (via the EMG harness 26) and assessing the resulting EMG responses (via the control unit 22), the surgical system 20 can assess whether (and the degree to which) such retraction impairs or adversely affects nerve function over time. With this information, a user may wish to periodically release the nerve root from retraction to allow nerve function to recover, thereby preventing or minimizing the risk of long-term or irreversible nerve impairment. As will be described in greater detail below, a similar neural pathology assessment can be undertaken, whereby an unhealthy nerve may be monitored to determine if nerve function improves due to a particular surgical procedure, such as spinal nerve decompression surgery.

The nerve retraction monitoring feature of the present invention is best viewed with regard to FIGS. 32 and 33. The neural pathology screen display 40 may include any of a variety of indicia capable of communicating parameters associated with the nerve retraction monitoring feature of the present invention to a surgeon, including but not limited to (in FIG. 32) a pre-operative recruitment curve graph 120, an intra-operative recruitment curve graph 122, and a differential display 124 indicating the relative difference between the stimulation threshold, slope, and saturation before the surgery and during the surgery. In this manner, the surgeon may intra-operatively assess if the retracted nerve is being damaged or otherwise compromised (such as due to a prolonged surgery), such that it can be temporarily released to allow it to recover before returning to retraction to continue with the surgery. It's believed that releasing the nerve root in this fashion will prevent or reduce the adverse effects (nerve function compromise) that may otherwise result from prolonged retraction.

FIG. 33 shows an alternate screen display including a stimulation threshold vs. time graph 130, slope vs. time graph 132, and saturation vs. time graph 134 for a given healthy nerve (as measured at a particular myotome) during nerve retraction monitoring. As will be appreciated, the start of nerve retraction initiates a progressive increase in stimulation threshold 130 and a concomitant progressive decrease in slope 132 and saturation 134, all of which cease and reverse at or close to the point the retraction is stopped. By monitoring this information, a surgeon can effectively determine when the nerve is in need of being released and, after that point, when it is generally safe to resume retraction.

The surgical effect nerve monitoring of the present invention is best viewed with regard to FIGS. 34 and 35. The neural pathology screen display 40 may include any of a variety of indicia capable of communicating parameters associated with the surgical effect nerve monitoring feature of the present invention to a surgeon, including but not limited to (in FIG. 34) a pre-operative recruitment curve graph 140, a post-operative recruitment curve graph 142, and a differential display 144 indicating the relative difference between the stimulation threshold, slope, and saturation before the surgery and after the surgery. In this manner, the surgeon may determine whether a previously unhealthy nerve has been positively affected by the surgery. This is particularly advantageous in assessing the effectiveness of spinal decompression surgery, wherein the effectiveness of the decompression may be determined by identifying whether the health of the compressed nerve root improves as a result of the surgery. This determination may also be made, by way of example, by (see FIG. 35) displaying various graphs to the user, such as a stimulation threshold vs. time graph 150, a slope vs. time graph 152, and saturation vs. time graph 154 for a given unhealthy nerve (as measured at a particular myotome) before, during, and after surgery. As can be seen, an improvement in nerve function due to surgery will cause the stimulation threshold to decrease post-operatively and the slope and saturation to increase post-operatively.

Although not shown, it is to be readily appreciated that the nerve retraction monitoring and surgical effect nerve monitoring techniques described above (both of which form part of the neural pathology monitoring feature of the present invention), should preferably be performed on different myotomes in that the former technique is particularly suited for assessing a healthy nerve and the latter is particularly suited for assessing an unhealthy nerve. Moreover, although not shown in FIGS. 32-35, the various graphs may be formed based on a compilation of EMG responses from more than one myotome without departing from the scope of the present invention.

While this invention has been described in terms of a best mode for achieving this invention's objectives, it will be appreciated by those skilled in the art that variations may be accomplished in view of these teachings without deviating from the spirit or scope of the present invention. For example, the present invention may be implemented using any combination of computer programming software, firmware or hardware. As a preparatory step to practicing the invention or constructing an apparatus according to the invention, the computer programming code (whether software or firmware) according to the invention will typically be stored in one or more machine readable storage mediums such as fixed (hard) drives, diskettes, optical disks, magnetic tape, semiconductor memories such as ROMs, PROMs, etc., thereby making an article of manufacture in accordance with the invention. The article of manufacture containing the computer programming code is used by either executing the code directly from the storage device, by copying the code from the storage device into another storage device such as a hard disk, RAM, etc. or by transmitting the code on a network for remote execution. As can be envisioned by one of skill in the art, many different combinations of the above may be used and accordingly the present invention is not limited by the scope of the appended claims.

Claims

1. A spinal access cannula comprising: a dilating cannula having an outer surface with a continuous cross section from a proximal end to a distal end of the dilating cannula except for a tapered portion near the distal end that tapers to a smaller diameter toward the distal end and having an inner surface defining an inner lumen extending from the proximal end to the distal end, the distal end of the dilating cannula having a distal central opening therethrough in communication with the inner lumen and in line with a central longitudinal axis of the dilating; anda single stimulation electrode fixed at the tapered portion and on the outer surface of the dilating cannula, and exposed at only a radial portion of the outer surface of the dilating cannula, wherein the radial portion comprises an arc on the outer surface of the dilating cannula, wherein the length of the arc is less than the circumference of the outer surface of the dilating cannula, wherein all other portions of the distal end of the dilating cannula has no exposed stimulation electrode.
2. A sequential dilator system comprising: at least three sequential dilating cannulas, each having an outer surface with a continuous cross section from a proximal end to a distal end of the sequential dilating cannula and having an inner surface defining an inner lumen extending from the proximal end to the distal end, the distal end of the sequential dilating cannula having a distal central opening therethrough in communication with the inner lumen and in line with a central longitudinal axis of the sequential dilating cannula, wherein one of the at least three sequential dilating cannulas comprises an outer surface with a continuous cross section from a proximal end to a distal end of the dilating cannula except for a tapered portion near the distal end that tapers to a smaller diameter toward the distal end; anda single stimulation electrode fixed at the tapered portion and on the outer surface of the one of the at least three sequential dilating cannulas, and exposed at only a radial portion of the outer surface of the one of the at least three sequential dilating cannulas, wherein the radial portion comprises an arc on the outer surface of the one of the at least three sequential dilating cannulas, wherein the length of the arc is less than the circumference of the outer surface of the one of the at least three sequential dilating cannulas, wherein all other portions of the distal end of the one of the at least three sequential dilating cannulas has no exposed stimulation electrode.
3. A sequential dilator system comprising: at least three sequential dilating cannulas, each having an outer surface with a continuous cross section from a proximal end to a distal end of the sequential dilating cannula and having an inner surface defining an inner lumen extending from the proximal end to the distal end, the distal end of the sequential dilating cannula having a distal central opening therethrough in communication with the inner lumen and in line with a central longitudinal axis of the sequential dilating cannula, wherein one of the at least three sequential dilating cannulas comprises an outer surface with a continuous cross section from a proximal end to a distal end of the dilating cannula except for a tapered portion near the distal end that tapers to a smaller diameter toward the distal end;a single stimulation electrode fixed at the tapered portion and on the outer surface of the one of the at least three sequential dilating cannulas, and exposed at only a radial portion of the outer surface of the one of the at least three sequential dilating cannulas, wherein the radial portion comprises an arc on the outer surface of the one of the at least three sequential dilating cannulas, wherein the length of the arc is less than the circumference of the outer surface of the one of the at least three sequential dilating cannulas, wherein all other portions of the distal end of the one of the at least three sequential dilating cannulas has no exposed stimulation electrode; andan electromyographic monitoring system configured for connection to each of the at least three sequential dilating cannulas and performing nerve detection of a spinal nerve when a respective one of the at least three sequential dilating cannulas is positioned in the access path toward the operative site in the region of the lumbar spine by stimulating the stimulation electrode and monitoring an electrical current level determined after a neuro-muscular onset response is detected via one or more return electrodes positioned on the patient's leg.
4. The sequential dilator system of claim 3, wherein each of the at least three sequential dilators comprises an electrical connector at the proximal end that is not aligned with the single stimulation electrode and that is configured for establishing electrical connection between the stimulation electrode and the electromyographic monitoring system.
5. The spinal access cannula of claim 1, further comprising a K-wire coupled to the stimulation electrode.
6. The sequential dilator system of claim 2, further comprising a K-wire coupled to the stimulation electrode.
7. The sequential dilator system of claim 3, further comprising a K-wire coupled to the stimulation electrode.

CROSS-REFERENCE TO RELATED APPLICATION(S)

This application is a continuation of U.S. patent application Ser. No. 14/278,862, filed on May 15, 2014, which is a continuation of U.S. patent application Ser. No. 13/763,816 (now U.S. Pat. No. 8,738,123), filed by Gharib et al., on Feb. 11, 2013 (the contents being incorporated herein by reference), which is a continuation of U.S. patent application Ser. No. 13/762,624 (now U.S. Pat. No. 8,768,450) filed by Gharib et al., on Feb. 8, 2013 (the contents being incorporated herein by reference), which is a continuation of U.S. patent application Ser. No. 13/568,236 (now U.S. Pat. No. 8,548,579) filed by Gharib et al., on Aug. 7, 2012 (the contents being incorporated herein by reference), which is a continuation of U.S. patent application Ser. No. 13/215,791 (now U.S. Pat. No. 8,244,343) filed by Gharib et al., on Aug. 23, 2011 (the contents being incorporated herein by reference), which is a continuation of U.S. patent application Ser. No. 12/423,559 (now U.S. Pat. No. 8,005,535) filed by Gharib et al., on Apr. 14, 2009 (the contents being incorporated herein by reference), which is a continuation of U.S. patent application Ser. No. 10/809,280 (now U.S. Pat. No. 7,522,953) filed by Gharib et al. on Mar. 25, 2004 (the contents being incorporated herein by reference), which is a continuation of PCT Patent Application Ser. No. PCT/US02/30617 filed on Sep. 25, 2002 and published as WO 03/026482 (the contents being incorporated herein by reference), which claims priority to U.S. Patent Provisional Application Ser. No. 60/325,424 filed by Gharib et al. on Sep. 25, 2001 (the contents being incorporated herein by reference).

US Referenced Citations (565)

Number	Name	Date	Kind
208227	Dorr	Sep 1878	A
509226	Kellogg	Nov 1893	A
972983	Arthur	Oct 1910	A
1003232	Cerbo	Oct 1910	A
1044348	Cerbo	Jun 1912	A
1328624	Graham	Jan 1920	A
1548184	Cameron	Aug 1925	A
1919120	O'Connor et al.	Jul 1933	A
2594086	Smith	Apr 1952	A
2704061	Amspacker	Mar 1955	A
2704064	Fizzell et al.	Mar 1955	A
2736002	Oriel	Feb 1956	A
2808826	Reiner et al.	Oct 1957	A
2840082	Salvatore	Jun 1958	A
3364929	Ide et al.	Jan 1968	A
3664329	Naylor	May 1972	A
3682162	Colyer	Aug 1972	A
3740839	Otte et al.	Jun 1973	A
3785368	McCarthy et al.	Jan 1974	A
3803716	Garnier	Apr 1974	A
3830226	Staub et al.	Aug 1974	A
3957036	Normann	May 1976	A
D245789	Shea et al.	Sep 1977	S
4099519	Warren	Jul 1978	A
4164214	Stark et al.	Aug 1979	A
4207897	Lloyd et al.	Jun 1980	A
4224949	Scott et al.	Sep 1980	A
4226228	Shin et al.	Oct 1980	A
4226288	Collins, Jr.	Oct 1980	A
4235242	Howson et al.	Nov 1980	A
4285347	Hess	Aug 1981	A
4291705	Severinghaus et al.	Sep 1981	A
4449532	Storz	May 1984	A
4461300	Christensen	Jul 1984	A
4512351	Pohndorf	Apr 1985	A
4515168	Chester et al.	May 1985	A
4519403	Dickhudt	May 1985	A
4545373	Christoudias	Oct 1985	A
4545374	Jacobson	Oct 1985	A
4561445	Berke et al.	Dec 1985	A
4562832	Wilder et al.	Jan 1986	A
4573448	Kambin	Mar 1986	A
4592369	Davis et al.	Jun 1986	A
4595013	Jones et al.	Jun 1986	A
4595018	Rantala	Jun 1986	A
4611597	Kraus	Sep 1986	A
4616635	Caspar et al.	Oct 1986	A
4633889	Talalla	Jan 1987	A
4658835	Pohndorf	Apr 1987	A
D295445	Freeman	Apr 1988	S
4744371	Harris	May 1988	A
4753223	Bremer	Jun 1988	A
4759377	Dykstra	Jul 1988	A
4784150	Voorhies et al.	Nov 1988	A
4807642	Brown	Feb 1989	A
D300561	Asa et al.	Apr 1989	S
4817587	Janese	Apr 1989	A
4892105	Prass	Jan 1990	A
4913134	Luque	Apr 1990	A
4917274	Asa et al.	Apr 1990	A
4917704	Frey et al.	Apr 1990	A
4926865	Oman	May 1990	A
4945896	Gade	Aug 1990	A
4950257	Hibbs et al.	Aug 1990	A
4962766	Herzon	Oct 1990	A
4964411	Johnson et al.	Oct 1990	A
5007902	Witt	Apr 1991	A
5015247	Michelson	May 1991	A
5045054	Hood et al.	Sep 1991	A
5052373	Michelson	Oct 1991	A
5058602	Brody	Oct 1991	A
5081990	Deletis	Jan 1992	A
5092344	Lee	Mar 1992	A
5127403	Brownlee	Jul 1992	A
5161533	Prass et al.	Nov 1992	A
5171279	Mathews	Dec 1992	A
5178133	Pena	Jan 1993	A
5190561	Graber	Mar 1993	A
5192327	Brantigan	Mar 1993	A
5195541	Obenchain	Mar 1993	A
5196015	Neubardt	Mar 1993	A
5215100	Spitz et al.	Jun 1993	A
5231974	Giglio et al.	Aug 1993	A
RE34390	Culver	Sep 1993	E
D340521	Heinzelman et al.	Oct 1993	S
5255691	Otten	Oct 1993	A
5261918	Phillips et al.	Nov 1993	A
5282468	Klepinski	Feb 1994	A
5284153	Raymond et al.	Feb 1994	A
5284154	Raymond et al.	Feb 1994	A
5295994	Bonutti	Mar 1994	A
5299563	Seton	Apr 1994	A
5312417	Wilk	May 1994	A
5313956	Knutsson et al.	May 1994	A
5313962	Obenchain	May 1994	A
5327902	Lemmen	Jul 1994	A
5331975	Bonutti	Jul 1994	A
5333618	Lekhtman et al.	Aug 1994	A
5342384	Sugarbaker	Aug 1994	A
5357983	Mathews	Oct 1994	A
5375067	Berchin	Dec 1994	A
5375594	Cueva	Dec 1994	A
5383876	Nardella	Jan 1995	A
5395317	Kambin	Mar 1995	A
5425772	Brantigan	Jun 1995	A
5433739	Sluijter et al.	Jul 1995	A
5450845	Alexgaard	Sep 1995	A
5458638	Kuslich et al.	Oct 1995	A
5472426	Bonati et al.	Dec 1995	A
5474057	Makower et al.	Dec 1995	A
5474558	Neubardt	Dec 1995	A
5480440	Kambin	Jan 1996	A
5482038	Ruff	Jan 1996	A
5484437	Michelson	Jan 1996	A
5487739	Aebischer et al.	Jan 1996	A
5509893	Pracas	Apr 1996	A
5514153	Bonutti	May 1996	A
5540235	Wilson	Jul 1996	A
5545222	Bonutti	Aug 1996	A
5549656	Reiss	Aug 1996	A
5560372	Cory	Oct 1996	A
5562736	Ray et al.	Oct 1996	A
5566678	Cadwell	Oct 1996	A
5569290	McAfee	Oct 1996	A
5571149	Liss et al.	Nov 1996	A
5579781	Cooke	Dec 1996	A
5593429	Ruff	Jan 1997	A
5599279	Slotman et al.	Feb 1997	A
5630813	Kieturakis	May 1997	A
5653761	Pisharodi	Aug 1997	A
5653762	Pisharodi	Aug 1997	A
5667508	Errico et al.	Sep 1997	A
5669909	Zdeblick et al.	Sep 1997	A
5671752	Sinderby et al.	Sep 1997	A
5681265	Maeda et al.	Oct 1997	A
5688223	Rosendahl	Nov 1997	A
5707359	Bufalini	Jan 1998	A
5711307	Smits	Jan 1998	A
5716415	Steffee	Feb 1998	A
5720751	Jackson	Feb 1998	A
5728046	Mayer et al.	Mar 1998	A
5728159	Stroever et al.	Mar 1998	A
5741253	Michelson	Apr 1998	A
5741261	Moskovitz et al.	Apr 1998	A
5759159	Masreliez	Jun 1998	A
5762629	Kambin	Jun 1998	A
5766252	Henry et al.	Jun 1998	A
5772661	Michelson	Jun 1998	A
5775331	Raymond	Jul 1998	A
5776144	Leysieffer et al.	Jul 1998	A
5779642	Nightengale	Jul 1998	A
5782774	Shmulewitz	Jul 1998	A
5785658	Benaron	Jul 1998	A
5792044	Foley et al.	Aug 1998	A
5797854	Hedgecock	Aug 1998	A
5797909	Michelson	Aug 1998	A
5800550	Sertich	Sep 1998	A
5807280	Davis	Sep 1998	A
5813978	Jako	Sep 1998	A
5814073	Bonutti	Sep 1998	A
5814084	Grivas et al.	Sep 1998	A
5830151	Hadzic et al.	Nov 1998	A
5851191	Gozani	Dec 1998	A
5851208	Trott	Dec 1998	A
5853373	Griffith et al.	Dec 1998	A
5860973	Michelson	Jan 1999	A
5862314	Jeddeloh	Jan 1999	A
5865845	Thalgott	Feb 1999	A
5872314	Clinton	Feb 1999	A
5885210	Cox	Mar 1999	A
5885219	Nightengale	Mar 1999	A
5888196	Bonutti	Mar 1999	A
5888224	Beckers et al.	Mar 1999	A
5891147	Moskovitz et al.	Apr 1999	A
5893890	Pisharodi	Apr 1999	A
5902231	Foley et al.	May 1999	A
5910315	Stevenson et al.	Jun 1999	A
5928139	Koros et al.	Jul 1999	A
5928158	Aristides	Jul 1999	A
5931777	Sava	Aug 1999	A
5935131	Bonutti et al.	Aug 1999	A
5938688	Schiff	Aug 1999	A
5944658	Koros et al.	Aug 1999	A
5954769	Rosenlicht	Sep 1999	A
5968098	Winslow	Oct 1999	A
5976094	Gozani et al.	Nov 1999	A
5976146	Ogawa et al.	Nov 1999	A
5993474	Ouchi	Nov 1999	A
6004262	Putz et al.	Dec 1999	A
6004312	Finneran	Dec 1999	A
6004326	Castro et al.	Dec 1999	A
6007487	Foley et al.	Dec 1999	A
6008433	Stone	Dec 1999	A
6010520	Pattison	Jan 2000	A
6015436	Schoenhoeffer	Jan 2000	A
6024696	Hoftman et al.	Feb 2000	A
6024697	Pisarik	Feb 2000	A
6027456	Feler et al.	Feb 2000	A
6033405	Winslow et al.	Mar 2000	A
6036638	Nwawka	Mar 2000	A
6038469	Karlsson et al.	Mar 2000	A
6038477	Kayyali	Mar 2000	A
6039761	Li et al.	Mar 2000	A
6042582	Ray	Mar 2000	A
6045580	Scarborough et al.	Apr 2000	A
6048342	Zucherman et al.	Apr 2000	A
6050992	Nichols	Apr 2000	A
6059829	Schlaepfer et al.	May 2000	A
6063088	Winslow	May 2000	A
6074343	Nathanson et al.	Jun 2000	A
6080105	Spears	Jun 2000	A
6083154	Liu et al.	Jul 2000	A
6083225	Winslow et al.	Jul 2000	A
6095987	Schmulewitz	Aug 2000	A
6096080	Nicholson et al.	Aug 2000	A
6104957	Alo et al.	Aug 2000	A
6104960	Duysens et al.	Aug 2000	A
6113638	Williams et al.	Sep 2000	A
6120503	Michelson	Sep 2000	A
6120506	Kohrs et al.	Sep 2000	A
6126660	Dietz	Oct 2000	A
6132386	Gozani et al.	Oct 2000	A
6132387	Gozani et al.	Oct 2000	A
6135965	Tumer et al.	Oct 2000	A
6139493	Koros et al.	Oct 2000	A
6142931	Kaji	Nov 2000	A
6146335	Gozani	Nov 2000	A
6152871	Foley et al.	Nov 2000	A
6159179	Simonson	Dec 2000	A
6159211	Boriani et al.	Dec 2000	A
6159215	Urbahns et al.	Dec 2000	A
6159230	Samuels	Dec 2000	A
6161047	King et al.	Dec 2000	A
6174311	Branch et al.	Jan 2001	B1
6181961	Prass	Jan 2001	B1
6187000	Davison et al.	Feb 2001	B1
6193756	Studer et al.	Feb 2001	B1
6196969	Bester et al.	Mar 2001	B1
6200347	Anderson et al.	Mar 2001	B1
6206822	Foley	Mar 2001	B1
6206826	Mathews et al.	Mar 2001	B1
6206922	Zdeblick et al.	Mar 2001	B1
6217509	Foley et al.	Apr 2001	B1
6224545	Cocchia et al.	May 2001	B1
6224549	Drongelen	May 2001	B1
6224607	Michelson	May 2001	B1
6224631	Kohrs	May 2001	B1
6241771	Gresser et al.	Jun 2001	B1
6245082	Gellman et al.	Jun 2001	B1
6251140	Marino et al.	Jun 2001	B1
6258125	Paul et al.	Jul 2001	B1
6259945	Epstein et al.	Jul 2001	B1
6264651	Underwood et al.	Jul 2001	B1
6266558	Gozani et al.	Jul 2001	B1
6273905	Streeter	Aug 2001	B1
6277149	Boyle et al.	Aug 2001	B1
6292701	Prass et al.	Sep 2001	B1
6306100	Prass	Oct 2001	B1
6308712	Shaw	Oct 2001	B1
6312392	Herzon	Nov 2001	B1
6319257	Carignan et al.	Nov 2001	B1
6325764	Griffith et al.	Dec 2001	B1
6334068	Hacker	Dec 2001	B1
6348058	Melkent et al.	Feb 2002	B1
6360750	Gerber et al.	Mar 2002	B1
6371968	Kogasaka et al.	Apr 2002	B1
6371989	Chauvin et al.	Apr 2002	B1
6383221	Scarborough et al.	May 2002	B1
6395007	Bhatnagar et al.	May 2002	B1
6409766	Brett	Jun 2002	B1
6416465	Brau	Jul 2002	B2
6425859	Foley et al.	Jul 2002	B1
6425887	McGuckin et al.	Jul 2002	B1
6425901	Zhu et al.	Jul 2002	B1
6432048	Francois	Aug 2002	B1
6432140	Lin	Aug 2002	B1
6440142	Ralph et al.	Aug 2002	B1
6442814	Landry et al.	Sep 2002	B1
6450952	Rioux et al.	Sep 2002	B1
6451015	Rittman, III et al.	Sep 2002	B1
6454806	Cohen et al.	Sep 2002	B1
6466817	Kaula et al.	Oct 2002	B1
6468205	Mollenauer et al.	Oct 2002	B1
6468207	Fowler, Jr.	Oct 2002	B1
6468311	Boyd et al.	Oct 2002	B2
6491724	Ferree	Dec 2002	B1
6500116	Knapp	Dec 2002	B1
6500128	Marino	Dec 2002	B2
6520907	Foley et al.	Feb 2003	B1
6524320	Dipoto	Feb 2003	B2
6535759	Epstein et al.	Mar 2003	B1
D472634	Anderson	Apr 2003	S
D472650	Green	Apr 2003	S
6564078	Marino et al.	May 2003	B1
6579244	Goodwin	Jun 2003	B2
6595998	Johnson et al.	Jul 2003	B2
6599294	Fuss et al.	Jul 2003	B2
6620157	Dabney et al.	Sep 2003	B1
6626905	Schmiel et al.	Sep 2003	B1
6635086	Lin	Oct 2003	B2
6645194	Briscoe et al.	Nov 2003	B2
6648895	Burkus et al.	Nov 2003	B2
6672019	Wenz et al.	Jan 2004	B1
6676703	Biscup	Jan 2004	B2
6679833	Smith et al.	Jan 2004	B2
6706067	Shimp et al.	Mar 2004	B2
6719692	Kleffner et al.	Apr 2004	B2
6746484	Liu et al.	Jun 2004	B1
6755841	Fraser et al.	Jun 2004	B2
6760616	Hoey et al.	Jul 2004	B2
6761739	Shepard	Jul 2004	B2
6770074	Michelson	Aug 2004	B2
6796985	Bolger et al.	Sep 2004	B2
6810281	Brock et al.	Oct 2004	B2
6819956	DiLorenzo	Nov 2004	B2
6824564	Crozet	Nov 2004	B2
6829508	Schulman et al.	Dec 2004	B2
6830570	Frey et al.	Dec 2004	B1
6847849	Mamo et al.	Jan 2005	B2
6849047	Goodwin	Feb 2005	B2
6855105	Jackson, III et al.	Feb 2005	B2
6869398	Obenchain	Mar 2005	B2
6871099	Whitehurst et al.	Mar 2005	B1
D503801	Jackson	Apr 2005	S
6902569	Palmer et al.	Jun 2005	B2
6916330	Simonson	Jul 2005	B2
6926728	Zucherman et al.	Aug 2005	B2
6929606	Ritland	Aug 2005	B2
6942698	Jackson	Sep 2005	B1
6945933	Branch	Sep 2005	B2
6951538	Ritland	Oct 2005	B2
6964687	Bernard et al.	Nov 2005	B1
6979353	Bresina	Dec 2005	B2
6984245	McGahan et al.	Jan 2006	B2
6986788	Paul et al.	Jan 2006	B2
6989031	Michelson	Jan 2006	B2
7018416	Hanson et al.	Mar 2006	B2
7047082	Schrom et al.	May 2006	B1
7050848	Hoey et al.	May 2006	B2
7079883	Marino et al.	Jul 2006	B2
7089059	Pless	Aug 2006	B1
D530423	Miles et al.	Oct 2006	S
7166113	Arambula et al.	Jan 2007	B2
7177677	Kaula et al.	Feb 2007	B2
7198598	Smith et al.	Apr 2007	B2
7207949	Miles et al.	Apr 2007	B2
7226451	Shluzas et al.	Jun 2007	B2
7261688	Smith et al.	Aug 2007	B2
7470236	Kelleher et al.	Dec 2008	B1
7473222	Dewey et al.	Jan 2009	B2
7481766	Lee et al.	Jan 2009	B2
7522953	Kaula et al.	Apr 2009	B2
7556601	Branch et al.	Jul 2009	B2
7582058	Miles et al.	Sep 2009	B1
7643884	Pond et al.	Jan 2010	B2
7691057	Miles et al.	Apr 2010	B2
7693562	Marino et al.	Apr 2010	B2
7717959	William et al.	May 2010	B2
7819801	Miles et al.	Oct 2010	B2
7892173	Miles et al.	Feb 2011	B2
7905840	Pimenta et al.	Mar 2011	B2
7918891	Curran et al.	Apr 2011	B1
7920922	Kaula et al.	Apr 2011	B2
7935051	Miles et al.	May 2011	B2
7962191	Marino et al.	Jun 2011	B2
7963927	Kelleher et al.	Jun 2011	B2
7991463	Kelleher et al.	Aug 2011	B2
8000782	Gharib et al.	Aug 2011	B2
8005535	Gharib et al.	Aug 2011	B2
8016767	Miles et al.	Sep 2011	B2
8021430	Michelson	Sep 2011	B2
8055349	Kaula et al.	Nov 2011	B2
8068912	Gharib et al.	Nov 2011	B2
8114019	Miles et al.	Feb 2012	B2
8133173	Miles et al.	Mar 2012	B2
8137284	Miles et al.	Mar 2012	B2
8172750	Miles et al.	May 2012	B2
8182423	Miles et al.	May 2012	B2
8187179	Miles et al.	May 2012	B2
8187334	Curran et al.	May 2012	B2
8192356	Miles et al.	Jun 2012	B2
8192357	Miles et al.	Jun 2012	B2
8244343	Gharib	Aug 2012	B2
8246686	Curran et al.	Aug 2012	B1
8251997	Michelson	Aug 2012	B2
8303458	Fukano et al.	Nov 2012	B2
8303498	Miles et al.	Nov 2012	B2
8303515	Pimenta et al.	Nov 2012	B2
8337410	Kelleher et al.	Dec 2012	B2
8343046	Miles et al.	Jan 2013	B2
8343224	Lynn et al.	Jan 2013	B2
8355780	Miles et al.	Jan 2013	B2
8361156	Curran et al.	Jan 2013	B2
8388527	Miles	Mar 2013	B2
8403841	Miles et al.	Mar 2013	B2
8439832	Miles et al.	May 2013	B2
8489170	Marino et al.	Jul 2013	B2
8500634	Miles et al.	Aug 2013	B2
8512235	Miles et al.	Aug 2013	B2
8523768	Miles et al.	Sep 2013	B2
8548579	Gharib et al.	Oct 2013	B2
8550994	Miles et al.	Oct 2013	B2
8556808	Miles et al.	Oct 2013	B2
8562521	Miles et al.	Oct 2013	B2
8574301	Curran et al.	Nov 2013	B2
8591432	Pimenta et al.	Nov 2013	B2
8602982	Miles et al.	Dec 2013	B2
8608804	Curran et al.	Dec 2013	B2
8628469	Miles et al.	Jan 2014	B2
8634904	Kaula et al.	Jan 2014	B2
8663100	Miles et al.	Mar 2014	B2
8672840	Miles et al.	Mar 2014	B2
8673005	Pimenta et al.	Mar 2014	B1
8679006	Miles et al.	Mar 2014	B2
8685105	Curran et al.	Apr 2014	B2
8696559	Miles et al.	Apr 2014	B2
8708899	Miles et al.	Apr 2014	B2
8738123	Gharib	May 2014	B2
8740783	Gharib et al.	Jun 2014	B2
8747307	Miles et al.	Jun 2014	B2
8753270	Miles et al.	Jun 2014	B2
8753271	Miles et al.	Jun 2014	B1
8764649	Miles et al.	Jul 2014	B2
8768450	Gharib	Jul 2014	B2
8780899	Tillman et al.	Jul 2014	B2
8812116	Kaula et al.	Aug 2014	B2
8814940	Curran et al.	Aug 2014	B2
8821396	Miles et al.	Sep 2014	B1
8915846	Miles et al.	Dec 2014	B2
8942801	Miles et al.	Jan 2015	B2
8945004	Miles et al.	Feb 2015	B2
8956283	Miles et al.	Feb 2015	B2
8958869	Kelleher et al.	Feb 2015	B2
8977352	Gharib	Mar 2015	B2
9014776	Marino et al.	Apr 2015	B2
9037250	Kaula et al.	May 2015	B2
9180021	Curran et al.	Nov 2015	B2
9186261	Pimenta et al.	Nov 2015	B2
9204871	Miles et al.	Dec 2015	B2
9265493	Miles et al.	Feb 2016	B2
9301743	Miles et al.	Apr 2016	B2
9314152	Pimenta et al.	Apr 2016	B2
9387090	Arnold et al.	Jul 2016	B2
9456783	Kaula et al.	Oct 2016	B2
9468405	Miles et al.	Oct 2016	B2
9474627	Curran et al.	Oct 2016	B2
9486329	Pimenta et al.	Nov 2016	B2
9572562	Miles et al.	Feb 2017	B2
9610071	Miles et al.	Apr 2017	B2
9636233	Arnold et al.	May 2017	B2
20010037123	Hancock	Nov 2001	A1
20010039949	Loubser	Nov 2001	A1
20010056280	Underwood et al.	Dec 2001	A1
20020007129	Marino	Jan 2002	A1
20020010392	Desai	Jan 2002	A1
20020016592	Branch et al.	Feb 2002	A1
20020065481	Cory et al.	May 2002	A1
20020072686	Hoey et al.	Jun 2002	A1
20020077632	Tsou	Jun 2002	A1
20020123744	Reynard	Sep 2002	A1
20020123780	Grill et al.	Sep 2002	A1
20020147387	Paolitto et al.	Oct 2002	A1
20020161415	Cohen et al.	Oct 2002	A1
20020193843	Hill et al.	Dec 2002	A1
20030032966	Foley et al.	Feb 2003	A1
20030070682	Wilson et al.	Apr 2003	A1
20030083688	Simonson	May 2003	A1
20030105503	Marino	Jun 2003	A1
20030105528	Shimp et al.	Jun 2003	A1
20030109928	Pasquet et al.	Jun 2003	A1
20030139648	Foley et al.	Jul 2003	A1
20030149341	Clifton	Aug 2003	A1
20030225405	Weiner	Dec 2003	A1
20030236544	Lunsford et al.	Dec 2003	A1
20040181165	Hoey et al.	Sep 2004	A1
20040199084	Kelleher et al.	Oct 2004	A1
20040225228	Ferree	Nov 2004	A1
20040230191	Frey et al.	Nov 2004	A1
20050004593	Simonson	Jan 2005	A1
20050004623	Miles et al.	Jan 2005	A1
20050033380	Tanner et al.	Feb 2005	A1
20050060006	Pflueger et al.	Mar 2005	A1
20050075578	Gharib et al.	Apr 2005	A1
20050080320	Lee et al.	Apr 2005	A1
20050149035	Pimenta et al.	Jul 2005	A1
20050149054	Gorek	Jul 2005	A1
20050182454	Gharib et al.	Aug 2005	A1
20050192575	Pacheco	Sep 2005	A1
20050203538	Lo et al.	Sep 2005	A1
20050228232	Gillinov et al.	Oct 2005	A1
20050277812	Myles	Dec 2005	A1
20060025703	Miles et al.	Feb 2006	A1
20060052826	Kim et al.	Mar 2006	A1
20060052828	Kim et al.	Mar 2006	A1
20060069315	Miles et al.	Mar 2006	A1
20060224078	Hoey et al.	Oct 2006	A1
20060235529	Ralph et al.	Oct 2006	A1
20060247658	Pond et al.	Nov 2006	A1
20070016097	Farquhar et al.	Jan 2007	A1
20070049931	Justis et al.	Mar 2007	A1
20070049962	Marino et al.	Mar 2007	A1
20070072475	Justin et al.	Mar 2007	A1
20070100212	Pimenta et al.	May 2007	A1
20070198062	Miles et al.	Aug 2007	A1
20070208228	Pavento et al.	Sep 2007	A1
20070260317	Ankney et al.	Nov 2007	A1
20070270842	Bankoski et al.	Nov 2007	A1
20070293782	Marino	Dec 2007	A1
20080058606	Miles et al.	Mar 2008	A1
20080058838	Steinberg	Mar 2008	A1
20080064976	Kelleher et al.	Mar 2008	A1
20080064977	Kelleher et al.	Mar 2008	A1
20080065135	Marino et al.	Mar 2008	A1
20080065144	Marino et al.	Mar 2008	A1
20080065178	Kelleher et al.	Mar 2008	A1
20080071191	Kelleher et al.	Mar 2008	A1
20080077138	Cohen et al.	Mar 2008	A1
20080097164	Miles et al.	Apr 2008	A1
20080103601	Biro et al.	May 2008	A1
20080146885	Protopsaltis	Jun 2008	A1
20080183214	Copp et al.	Jul 2008	A1
20080221394	Melkent et al.	Sep 2008	A1
20080288077	Reo et al.	Nov 2008	A1
20080300465	Feigenwinter et al.	Dec 2008	A1
20090030519	Falahee	Jan 2009	A1
20090124860	Miles et al.	May 2009	A1
20090132049	Carver et al.	May 2009	A1
20090138050	Ferree	May 2009	A1
20090138090	Hurlbert et al.	May 2009	A1
20090192403	Gharib et al.	Jul 2009	A1
20090204016	Gharib et al.	Aug 2009	A1
20100069783	Miles et al.	Mar 2010	A1
20100106251	Kast	Apr 2010	A1
20100130827	Pimenta et al.	May 2010	A1
20100152603	Miles et al.	Jun 2010	A1
20100160738	Miles et al.	Jun 2010	A1
20100174146	Miles	Jul 2010	A1
20100174148	Miles et al.	Jul 2010	A1
20100228350	Gornet et al.	Sep 2010	A1
20110046448	Paolitto et al.	Feb 2011	A1
20110218631	Woodburn, Sr. et al.	Sep 2011	A1
20110313530	Gharib et al.	Dec 2011	A1
20120238822	Miles	Sep 2012	A1
20120238893	Farquhar et al.	Sep 2012	A1
20130331943	Arnold et al.	Dec 2013	A1
20140235950	Miles et al.	Aug 2014	A1
20140288374	Miles et al.	Sep 2014	A1
20140288375	Miles et al.	Sep 2014	A1
20150150693	Gharib et al.	Jun 2015	A1
20150157227	Kelleher et al.	Jun 2015	A1
20150157228	Marino et al.	Jun 2015	A1
20150282948	Arnold et al.	Oct 2015	A1
20160120530	Miles et al.	May 2016	A1
20160174958	Miles et al.	Jun 2016	A1
20160174959	Miles et al.	Jun 2016	A1
20160192921	Pimenta et al.	Jul 2016	A1
20160374613	Kaula et al.	Dec 2016	A1
20170007421	Curran et al.	Jan 2017	A1
20170020503	Miles et al.	Jan 2017	A1
20170027712	Pimenta et al.	Feb 2017	A1
20170143514	Gharib et al.	May 2017	A1
20170143515	Gharib et al.	May 2017	A1
20170156580	Miles et al.	Jun 2017	A1
20170164938	Miles et al.	Jun 2017	A1
20170172558	Miles et al.	Jun 2017	A1

Foreign Referenced Citations (44)

Number	Date	Country
299 08 259	Jul 1999	DE
100 48 790	Apr 2002	DE
0 334 116	Sep 1989	EP
0 567 424	Oct 1993	EP
0 972 538	Jan 2000	EP
1 002 500	May 2000	EP
2 795 624	Jan 2001	FR
793186	May 1990	JP
10-14928	Mar 1996	JP
3019990007098	Nov 1999	KR
9428824	Dec 1994	WO
9700702	Jan 1997	WO
9823324	Jun 1998	WO
9952446	Oct 1999	WO
0027291	May 2000	WO
0038574	Jul 2000	WO
0044288	Aug 2000	WO
WO-0062660	Oct 2000	WO
0066217	Nov 2000	WO
0067645	Nov 2000	WO
0108563	Feb 2001	WO
0137728	May 2001	WO
0160263	Aug 2001	WO
02054960	Jul 2002	WO
02058780	Aug 2002	WO
0271953	Sep 2002	WO
0287678	Nov 2002	WO
03005887	Jan 2003	WO
03026482	Apr 2003	WO
03037170	May 2003	WO
WO-03084398	Oct 2003	WO
WO-2004064634	Aug 2004	WO
05013805	Feb 2005	WO
05030318	Apr 2005	WO
06042241	Apr 2006	WO
06066217	Jun 2006	WO
WO-2007035925	Mar 2007	WO
WO-2007136784	Nov 2007	WO
WO-2009055034	Apr 2009	WO
WO-2011059491	May 2011	WO
WO-2011059498	May 2011	WO
WO-2012026981	Mar 2012	WO
WO-2012103254	Aug 2012	WO
WO-2013028571	Feb 2013	WO

Non-Patent Literature Citations (257)

Entry
Anatomy of the Lumbar Spine in MED TM MicroEndoscopic Discectomy (1997 Ludann Grand Rapids MI), 14 pgs.
Dirksmeier et al., “Microendoscopic and Open Laminotomy and Discectomy in Lumbar Disc Disease” Seminars in Spine Surgery, 1999, 11(2): 138-146.
METRx Delivered Order Form, 1999, 13 pages.
Medtronic Sofamor Danek “METRx™ MicroDiscectomy System,” Medtronic Sofamor Danek USA, 2000, 21 pgs.
Medtronic Sofamor Danek “METRx System Surgical Technique,” 2004, 22 pages.
“MetRx System MicroEndoscopic Discectomy: An Evolution in Minimally Invasive Spine Surgery,” Sofamor Danek, 1999, 6 pages.
Smith and Foley “MetRx System MicroEndoscopic Discectomy: Surgical Technique” Medtronic Sofamor Danek, 2000, 24 pages.
“Sofamor Danek MED Microendoscopic Discectomy System Brochure” including Rapp “New endoscopic lumbar technique improves access preserves tissue” Reprinted with permission from: Orthopedics Today, 1998, 18(1): 2 pages.
Japanese Patent Office JP Patent Application No. 2006-528306 Office Action with English Translation, dated Jun. 10, 2009, 4 pages.
Plaintiffs' Preliminary Invalidity Contentions re U.S. Pat. Nos. 7,207,949; 7,470,236 and 7,582,058, Sep. 18, 2009, 19 pages.
Plaintiffs' Preliminary Invalidity Contentions-Appendices, Sep. 18, 2009, 191 pages.
Plaintiffs' Supplemental Preliminary Invalidity Contentions re U.S. Pat. Nos. 7,207,949, 7,470,236, and 7,582,058, Sep. 29, 2009, 21 pages.
Plaintiffs' Supplemental Preliminary Invalidity Contentions—Appendices, Sep. 29, 2009, 294 pages.
Axon 501(k) Notification: Epoch 2000 Neurological Workstation, Dec. 3, 1997, 464 pages.
Foley and Smith, “Microendoscopic Discectomy,” Techniques in Neurosurgery, 1997, 3(4):301-307.
Medtronic Sofamor Danek “Union™ / Union-L™ Anterior & Lateral Impacted Fusion Devices: Clear choice of stabilization,” Medtronic Sofamor Danek, 2000, 4 pages.
NuVasive Vector™ Cannulae, 2000, 1 page.
NuVasive Triad™ Tri-Columnar Spinal EndoArthrodesis™ via Minimally Invasive Guidance, 2000, 1 page (prior to Sep. 25, 2003).
NuVasive Triad™ Cortical Bone Allograft, 2000, 1 page (prior to Sep. 25, 2003).
NuVasive Vertebral Body Access System, 2000, 1 page.
Marina, “New Technology for Guided Navigation with Real Time Nerve Surveillance for Minimally Invasive Spine Discectomy & Arthrodesis,” Spineline, 2000, p. 39.
NuVasive “INS-1 Screw Test,” 2001, 10 pages.
NuVasive letter re 510k Neuro Vision JJB System, Oct. 16, 2001, 5 pages.
NuVasive letter re 510k Guided Arthroscopy System, Oct. 5, 1999, 6 pages.
NuVasive letter re 510k INS-1 Intraoperative Nerve Surveillance System, Nov. 13, 2000, 7 pages.
“NuVasiveTM Receives Clearance to Market Two Key Elem Minimally Invasive Spine Surgery System,” Nov. 27, 2001, 20 pages.
Schick et al., “Microendoscopic lumbar discectomy versus open surgery: an intraoperative EMG study,” Eur Spine J, 2002, 11: 20-26.
NuVasive letter re: 510(k) for Neurovision JJB System (Summary), Sep. 25, 2001, 28 pages.
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), Jul. 3, 2003, 18 pages.
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), Mar. 1, 2004, 16 pages.
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), May 26, 2005, 17 pages.
NuVasive letter re: 510(k) Premarket Notification: Neurovision JJB System (Device Description), Jun. 24, 2005, 16 pages.
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), Sep. 14, 2006, 17 pages.
NuVasive 510(k) Premarket Notification: Neurovision JJB System (Device Description), Aug. 20, 2007, 8 pages.
NuVasive letter re: 510(k) Premarket Notification: Guided Spinal Arthroscopy System (Device Description), Feb. 1, 1999, 40 pages.
NuVasive 510(k) Premarket Notification: Spinal System (Summary), Apr. 12, 2004, 10 pages.
NuVasive 510(k) Summary NIM Monitor, Sep. 4, 1998, 4 pages.
NuVasive correspondence re 510(k) Premarket Notification INS-1 Intraoperative Nerve Surveillance System: Section IV Device Description, pp. 12-51 (prior to Sep. 25, 2003).
Isley et al., “Recent Advances in Intraoperative Neuromonitoring of Spinal Cord Function: Pedicle Screw Stimulation Techniques,” American Journal of Electroneurodiagnostic Technology, Jun. 1997, 37(2): 93-126.
Mathews et al., “Laparoscopic Discectomy with Anterior Lumbar Interbody Fusion,” Spine, 1995, 20(16): 1797-1802.
Rose et al., “Persistently Electrified Pedicle Stimulation Instruments in Spinal Instrumentation: Techniques and Protocol Development,” Spine, 1997, 22(3): 334-343.
“Electromyography System,” International Search report from International Application No. PCT/US00/32329, dated Apr. 27, 2001, 9 pages.
“Nerve Proximity and Status Detection System and Method,” International Search Report from International Application No. PCT/US01/18606, dated Oct. 18, 2001, 6 pages.
“Relative Nerve Movement and Status Detection System and Method,” International Search Report from International Application No. PCT/US01/18579, dated Jan. 15, 2002, 6 pages.
“System and Method for Deteimining Nerve Proximity Direction and Pathology During Surgery,” International Search Report from International Application No. PCT/US02/22247, dated Mar. 27, 2003, 4 pages.
“System and Methods for Determining Nerve Direction to a Surgical Instrument,” International Search Report from International Application No. PCT/US03/02056, dated Aug. 12, 2003, 5 pages.
“Systems and Methods for Perfoiiiiing Percutaneous Pedicle Integrity Assessments,” International Search Report from International Application No. PCT/US02/35047, dated Aug. 11, 2003, 5 pages.
“Systems and Methods for Perfoiiiiing Surgery Procedures and Assessments,” International Search Report from International Application No. PCT/US02/30617, dated Jun. 5, 2003, 4 pages.
Lenke et al., “Triggered Electromyographic Threshold for Accuracy of Pedicle Screw Placement,” Spine, 1995, 20(4): 1585-1591.
“Brackmann II EMG System,” Medical Electronics, 1999, 4 pages.
“Neurovision SE Nerve Locator/Monitor”, RLN Systems Inc. Operators Manual, 1999, 22 pages.
“The Brackmann II EMG Monitoring System,” Medical Electronics Co. Operator's Manual Version 1.1, 1995, 50 pages.
“The Nicolet Viking IV,” Nicolet Biomedical Products, 1999, 6 pages.
Anderson et al., “Pedicle screws with high electrical resistance: a potential source of error with stimulus-evoked EMG,” Spine, Department of Orthopaedic Surgery University of Virginia, Jul. 15, 2002, 27(14): 1577-1581.
Bose et al., “Neurophysiologic Monitoring of Spinal Nerve Root Function During Instrumented Posterior Lumber Spine Surgery,” Spine, 2002, 27(13):1444-1450.
Calancie et al., “Stimulus-Evoked EMG Monitoring During Transpedicular Lumbosacral Spine Instrumentation” Spine, 1994, 19(24): 2780-2786.
Clements et al., “Evoked and Spontaneous Electromyography to Evaluate Lumbosacral Pedicle Screw Placement,” Spine, 1996, 21(5): 600-604.
Danesh-Clough et al. ,“The Use of Evoked EMG in Detecting Misplaced Thoracolumbar Pedicle Screws,” Spine, Orthopaedic Department Dunedin Hospital, Jun. 15, 2001, 26(12): 1313-1316.
Darden et al., “A Comparison of Impedance and Electromyogram Measurements in Detecting the Presence of Pedicle Wall Breakthrough,” Spine, Charlotte Spine Center, North Carolina, Jan. 15, 1998, 23(2): 256-262.
Ebraheim et al., “Anatomic Relations Between the Lumbar Pedicle and the Adjacent Neural Structures,” Spine, Department of Orthopaedic Surgery Medical College of Ohio, Oct. 15, 1997, 22(20): 2338-2341.
Ford et al. “Electrical Characteristics of Peripheral Nerve Stimulators Implications for Nerve Localization,” Regional Anesthesia, 1984, 9: 73-77.
Glassman et al., “A Prospective Analysis of Intraoperative Electromyographic Monitoring of Pedicle Screw Placement With Computed Tomographic Scan Confirmation,” Spine, 1995, 20(12): 1375-1379.
Greenblatt et al., “Needle Nerve Stimulator-Locator: Nerve Blocks with a New Instrument for Locating Nerves,” Anesthesia& Analgesia, 1962, 41(5): 599-602.
Haig, “Point of view,” Spine, 2002, 27(24): 2819.
Haig et al., “The Relation Among Spinal Geometry on MRI, Paraspinal Electromyographic Abnormalities, and Age in Persons Referred for Electrodiagnostic Testing of Low Back Symptoms,” Spine, Department of Physical Medicine and Rehabilitation University of Michigan, Sep. 1, 2002, 27(17): 1918-1925.
Holland et al., “Higher Electrical Stimulus Intensities are Required to Activate Chronically Compressed Nerve Roots: Implications for Intraoperative Electromyographic Pedicle Screw Testing,” Spine, Department of Neurology, Johns Hopkins University School of Medicine, Jan. 15, 1998, 23(2): 224-227.
Holland, “Intraoperative Electromyography During Thoracolumbar Spinal Surgery,” Spine, 1998, 23(17): 1915-1922.
Journee et al., “System for Intra-Operative Monitoring of the Cortical Integrity of the Pedicle During Pedicle Screw Placement in Low-Back Surgery: Design and Clinical Results,” Sensory and Neuromuscular Diagnostic Instrumentation and Data Analysis I, 18th Annual International Conference on Engineering in Medicine and Biology Society, Amsterdam, 1996, pp. 144-145.
Maguire et al., “Evaluation of Intrapedicular Screw Position Using Intraoperative Evoked Electromyography,” Spine, 1995, 20(9): 1068-1074.
Martin et al. “Initiation of Erection and Semen Release by Rectal Probe Electrostimulation (RPE),” The Journal of Urology, The Williams& Wilkins Co., 1983, 129: 637-642.
Minahan et al., “The Effect of Neuromuscular Blockade on Pedicle Screw Stimulation Thresholds” Spine, Department of Neurology, Johns Hopkins University School of Medicine, Oct. 1, 2000, 25(19): 2526-2530.
Pither et al., “The Use of Peripheral Nerve Stimulators for Regional Anesthesia: Review of Experimental Characteristics Technique and Clinical Applications,” Regional Anesthesia, 1985, 10:49-58.
Raj et al., “Infraclavicular Brachial Plexus Block—A New Approach” Anesthesia and Analgesia, 1973, (52)6: 897-904.
Raj et al., “The Use of Peripheral Nerve Stimulators for Regional Anesthesia,” Clinical Issues in Regional Anesthesia, 1985, 1(4):1-6.
Raj et al., “Use of the Nerve Stimulator for Peripheral Blocks,” Regional Anesthesia, Apr.-Jun. 1980, pp. 14-21.
Raymond et al., “The Nerve Seeker: A System for Automated Nerve Localization,” Regional Anesthesia, 1992, 17(3): 151-162.
Shafik, “Cavernous Nerve Simulation through an Extrapelvic Subpubic Approach: Role in Penile Erection,” Eur. Urol, 1994, 26: 98-102.
Toleikis et al., “The Usefulness of Electrical Stimulation for Assessing Pedicle Screw Replacements,” Journal of Spinal Disorder, 2000, 13(4): 283-289.
Medtronic Sofamor Danek “Union™ / Union-L™ Anterior & Lateral Impacted Fusion Devices: Surgical Technique” Medtronic Sofamor Danek, 2001, 20 pages.
Defendant's Disclosure of Asserted Claims and Preliminary Infringement Contentions Regarding U.S. Pat. Nos. 7,207,949; 7,470,236 and 7,582,058, Aug. 31, 2009, 21 pages.
Bergey et al., “Endoscopic Lateral Transpsoas 1681-1688 Approach to the Lumbar Spine,” Spine, 2004, 29(15): 1681-1688.
Dezawa et al., “Retroperitoneal Laparoscopic Lateral Approach to the Lumbar Spine: A New Approach, Technique, and Clinical Trial,” Journal of Spinal Disorders, 2000, 13(2): 138-143.
Gardocki, “Tubular diskectomy minimizes collateral damage: A logical progression moves spine surgery forward,” AAOS Now, 2009, 5 pages.
Hovorka et al., “Five years' experience of retroperitoneal lumbar and thoracolumbar surgery,” Eur. Spine J., 2000, 9(1): S30-S34.
Kossmann et al., “The use of a retractor system (SynFrame) for open, minimal invasive reconstruction of the anterior column of the thoracic and lumbar spine,” Eur Spine J., 2001, 10: 396-402.
Mayer, “A New Microsurgical Technique for Minimally Invasive Anterior Lumbar Interbody Fusion,” Spine, 1997, 22(6): 691-699.
Mayer, “The ALIF Concept,” Eur Spine J., 2000, 9(1): S35-S43.
Mayer and Wiechert, “Microsurgical Anterior Approaches to the Lumbar Spine for Interbody Fusion and Total Disc Replacement,” Neurosurgery, 2002, 51(2): 159-165.
McAfee et al., “Minimally Invasive Anterior Retroperitoneal Approach to the Lumbar Spine: Emphasis on the Lateral BAK,” Spine, 1998, 23(13): 1476-1484.
Rao, et al. “Dynamic retraction of the psoas muscle to expose the lumbar spine using the retroperitoneal approach,” J. Neurosurg Spine, 2006, 5: 468-470.
Wolfla et al., “Retroperitoneal lateral lumbar interbody fusion with titanium threaded fusion cages,” J. Neurosurg (Spine 1), 2002, 96: 50-55.
Larson and Maiman, “Surgery of the Lumbar Spine,” Thieme Medical Publishers, Inc., 1999, pp. 305-319.
Medtronic XOMED Surgical Products, Inc., NIM-Response Nerve Integrity Monitor Intraoperative EMG Monitor User's Guide, Revision B, 2000, 47 pages.
“NuVasive's spine surgery system cleared in the US,” Pharm & Medical Industry Week, Dec. 10, 2001, 1 page.
Pimenta, “Initial Clinical Results of Direct Lateral, Minimally Invasive Access to the Lumbar Spine for Disc Nucleus Replacement Using a Novel Neurophysiological Monitoring System.” The 9th IMAST, May 2002, 1 page.
Pimenta et al., “The Lateral Endoscopic Transpsoas Retroperitoneal Approach (Letra) for Implants in the Lumbar Spine,” World Spine II—Second Interdisciplinary Congress on Spine Care, Aug. 2003, 2 pages.
Crock, H.V. MD., “Anterior Lumbar Interbody Fusion,” Clinical Orthopaedics and Related Research, Number One Hundred Sixty Five, 1982, pp. 157-163, 13 pages.
Mayer and Brock, “Percutaneous endoscopic discectomy: surgical technique and preliminary results compared to microsurgical discectomy,” J. Neurosurg., 1993, 78: 216-225.
Schaffer and Kambin, “Percutaneous Posterolateral Lumbar Discectomy and Decompression with a 6.9-Millimeter Cannula,” The Journal of Bone and Joint Surgery, 1991, 73A(6): 822-831.
Friedman, “Percutaneous discectomy: An alternative to chemonucleolysis,” Neurosurgery, 1983, 13(5): 542-547.
Request for Inter PartesReexamination in re U.S. Pat. No. 7,905,840, dated Feb. 8, 2012, 204 pages.
Brau, “Chapter 22: Anterior Retroperitoneal Muscle-Sparing approach to L2-S1 of the Lumbar Spine,” Surgical Approaches to the Spine. Robert G. Watkins, MD. (ed) 2003. pp. 165-181.
Kossmann et al., “Minimally Invasive Vertebral Replacement with Cages in Thoracic and Lumbar Spine,” European Journal of Trauma, 2001, 27: 292-300.
Mayer H. M. (ed.) Minimally Invasive Spine Surgery: A Surgical Manual. 2000. 51 pages.
Pimenta et al., “Implante de protese de nucleo pulposo: analise inicial,” Journal Brasileiro de Neurocirurgia, 2001, 12(2): 93-96.
Traynelis, “Spinal Arthroplasty,” Neurological Focus, 2002, 13(2): 12 pages.
Zdeblick, Thomas A. (ed.). Anterior Approaches to the Spine. 1999. 43 pages.
Amended Complaint for NuVasive, Inc. v. Globus Medical, Inc., Case No. 1:10-cv-0849 (D. Del., Oct. 5, 2010), 28 pages.
Request for Inter PartesReexamination in re U.S. Pat. No. 7,819,801, dated Feb. 8, 2012, 89 pages.
Kossman et al., “The use of a retractor system (SynFrame) for open, minimal invasive reconstruction of the anterior column of the thoracic and lumbar spine,” Eur Spine J, 2001, 10: 396-402.
de Peretti et al., “New possibilities in L2-L5 lumbar arthrodesis using a lateral retroperitoneal approach assisted by laparoscopy: preliminary results,” Eur Spine J, 1996, 5: 210-216.
Litwin et al., “Hand-assisted laparoscopic surgery (HALS) with the handport system,” Annals of Surgery, 2000, 231(5): 715-723.
Acland's Video Atlas of Human Anatomy, Section 3.1.7: Paravertebral Muscles. Available online: http://aclandanatomy.com/abstract/4010463. Accessed Jul. 11, 2012.
MedlinePlus, a Service of the U.S. National Library of Medicine and National Institutes of Health. Available online: http://www.nlm.nih.gov/medlineplus/. Accessed Jul. 11, 2012.
Baulot et al., Adjuvant Anterior Spinal Fusion Via Thoracoscopy, Lyon Chirurgical, 1994, 90(5): 347-351 including English Translation and Certificate of Translation.
Leu et al., “Percutaneous Fusion of the Lumbar Spine,” Spine, 1992, 6(3): 593-604.
Rosenthal et al., “Removal of a Protruded Thoracic Disc Using Microsurgical Endoscopy,” Spine, 1994, 19(9): 1087-1091.
Counterclaim Defendants' Corrected Amended Invalidity Contentions re U.S. Pat. Nos. 8,000,782; 8,005,535; 8,016,767; 8,192,356; 8,187,334; 8,361,156, D652,922; D666,294 re Case No. 3:12-cv-02738-CAB(MDD), dated Aug. 19, 2013, 30 pages.
Petition for Inter Partes Review IPR2014-00034, filed Oct. 8, 2013, 65 pages.
Petition for Inter Partes Review IPR2014-00035, filed Oct. 8, 2013, 65 pages.
Declaration of Lee Grant, from IPR2014-00034, Oct. 7, 2013, 36 pages.
Declaration of David Hacker from IPR2014-00034, Oct. 4, 2013, 64 pages.
NuVasive, Inc's Opening Claim Construction Brief Regarding U.S. Pat. Nos. 8,000,782; 8,005,535; 8,016,767; 8,192,356; 8,187,334; 8,361,156; D652,922; and 5,676,146 C2, filed Sep. 3, 2013, in Warsaw Orthopedic, Inc. v. NuVasive, Inc., No. 3:12-cv-02738-CAB-MDD (S.D. Cal.)., 34 pages.
Petition for Inter Partes Review IPR2014-00073, filed Oct. 18, 2013, 65 pages.
Petition for Inter Partes Review IPR2014-00074, filed Oct. 18, 2013, 65 pages.
Petition for Inter Partes Review IPR2014-00075, filed Oct. 21, 2013, 66 pages.
Petition for Inter Partes Review IPR2014-00076, filed Oct. 21, 2013, 65 pages.
Petition for Inter Partes Review IPR2014-00081, filed Oct. 22, 2013, 64 pages.
Petition for Inter Partes Review IPR2014-00087, filed Oct. 22, 2013, 64 pages.
Declaration of Lee Grant, from IPR2014-00073, Oct. 9, 2013, 36 pages.
Declaration of David Hacker, from IPR2014-00073, Oct. 10, 2013, 64 pages.
U.S. Appl. No. 60/392,214, filed Jun. 26, 2002, 97 pages.
Amendment in reply to Feb. 15, 2012 Office Action in U.S. Appl. No. 12/635,418, dated Mar. 16, 2012, 24 pages.
Decision on Appeal in Inter Partes Reexamination Control No. 95/001,247, dated Mar. 18, 2013, 49 pages.
Declaration of Lee Grant, from IPR2014-00074, Oct. 9, 2013, 36 pages.
Declaration of David Hacker, from IPR2014-00074, Oct. 10, 2013, 64 pages.
Declaration of David Hacker, from IPR2014-00075, Oct. 10, 2013, 64 pages.
Amendment in reply to Action of Feb. 7, 2011 and Notice of May 12, 2011, in U.S. Appl. No. 11/789,284, dated May 17, 2011, 16 pages.
Notice of Allowance in U.S. Appl. No. 11/789,284, dated Jul. 18, 2011, 8 pages.
Office action from U.S. Appl. No. 11/789,284, dated Feb. 7, 2011, 10 pages.
Merriam-Webster's Collegiate Dictionary, p. 65 (10th ed. 1998).
Declaration of Lee Grant, from IPR2014-00076, Oct. 9, 2013, 36 pages.
Moed et al., “Evaluation of Intraoperative Nerve-Monitoring During Insertion of an Iliosacral Implant in an Animal Model, Journal of Bone and Joint Surgery,” 1999, 81-A(11): 9.
Declaration of Lee Grant, from IPR2014-0081, Oct. 9, 2013, 36 pages.
Declaration of David Hacker from IPR2014-00081, Oct. 10, 2013, 64 pages.
U.S. Appl. No. 60/325,424, filed Sep. 25, 2001, 346 pages.
Declaration of Lee Grant, from IPR2014-0087, Oct. 9, 2013, 36 pages.
Declaration of David Hacker from IPR2014-00087, Oct. 10, 2013, 64 pages.
Request for Inter Partes Reexamination in re: U.S. Pat. No. 7,691,057, dated Feb. 8, 2012, 50 pages.
Declaration of Daniel Schwartz, Ph.D. from IPR2014-00034, Oct. 7, 2013, 1056 pages.
Declaration of Daniel Schwartz, Ph.D. from IPR2014-00035, Oct. 7, 2013, 661 pages.
510(K) No. K002677, approved by the FDA on Nov. 13, 2000, 634 pages.
510(K) No. K013215, approved by the FDA on Oct. 16, 2001, 376 pages.
Declaration of Robert G. Watkins, from IPR2014-00073, Oct. 18, 2013, 1101 pages.
Declaration of Daniel Schwartz, from IPR2014-00073, Oct. 12, 2013, 1226 pages.
Declaration of Robert G. Watkins, from IPR2014-00074, Oct. 18, 2013, 548 pages.
Declaration of Daniel Schwartz, from IPR2014-00074, Oct. 12, 2013, 565 pages.
Declaration of Robert G. Watkins, from IPR2014-00075, Oct. 18, 2013, 674 pages.
Declaration of Daniel Schwartz, from IPR2014-00075, Oct. 12, 2013, 1107 pages.
Declaration of Robert G. Watkins, from IPR2014-00076, Oct. 18, 2013, 543 pages.
Declaration of Daniel Schwartz, from IPR2014-00076, Oct. 12, 2013, 1247 pages.
Declaration of David Hacker, from IPR2014-00076, Oct. 10, 2013, 64 pages.
Declaration of Daniel Schwartz, from IPR2014-0081, Oct. 21, 2013, 585 pages.
Declaration of Daniel Schwartz from IPR2014-0087, Oct. 21, 2013, 585 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00034, dated Jan. 15, 2014, 66 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00034, dated Apr. 8, 2014, 35 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00035, dated Jan. 15, 2014, 42 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00035, dated Apr. 8, 2014, 12 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00073, dated Jan. 31, 2014, 64 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00073, dated Apr. 8, 2014, 34 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00074, dated Jan. 31, 2014, 68 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00074, dated Apr. 8, 2014, 28 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00075, dated Jan. 31, 2014, 54 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00075, dated Apr. 8, 2014, 23 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00076, dated Jan. 31, 2014, 58 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00076, dated Apr. 8, 2014, 11 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00081, dated Jan. 31, 2014, 47 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00081, dated Apr. 8, 2014, 31 pages.
Patent Owner NuVasive Inc's Preliminary Response from IPR2014-00087, dated Jan. 31, 2014, 51 pages.
Patent Trial and Appeal Board Decision from IPR 2014-00087, dated Apr. 8, 2014, 31 pages.
Final Written Decision from IPR 2014-00034, dated Apr. 3, 2015, 48 pages.
Final Written Decision from IPR 2014-00073, dated Apr. 3, 2015, 36 pages.
Final Written Decision from IPR 2014-00074, dated Apr. 3, 2015, 31 pages.
Final Written Decision from IPR 2014-00075, dated Apr. 3, 2015, 39 pages.
Final Written Decision from IPR 2014-00081, dated Apr. 3, 2015, 44 pages.
Final Written Decision from IPR 2014-00087, dated Apr. 3, 2015, 36 pages.
INS-1 Guide Dec. 31, 2000, Part III.
Co-pending U.S. Appl. No. 15/498,296, filed Apr. 26, 2017.
Co-pending U.S. Appl. No. 90/013,464, filed Mar. 6, 2015.
Co-pending U.S. Appl. No. 90/013,546, filed Jul. 8, 2015.
Co-pending U.S. Appl. No. 90/013,605, filed Oct. 8, 2015.
Co-pending U.S. Appl. No. 95/001,247, filed Oct. 27, 2009.
Co-pending U.S. Appl. No. 95/001,888, filed Feb. 9, 2012.
Co-pending U.S. Appl. No. 95/001,890, filed Feb. 9, 2012.
European Search Report dated Apr. 7, 2015 for EP Application No. 12826211.0.
European Search Report dated Aug. 2, 2012 for EP Application No. 12001129.1.
European Search Report dated Sep. 28, 2009 for EP Application No. 02778359.6.
In re: Nuvasive, Inc., in 2015-1670 decided on Dec. 7, 2016, 13 Pages.
In re: Nuvasive, Inc., in 2015-1672, 2015-1673 decided on Nov. 9, 2016, 16 Pages.
In re: Nuvasive, Inc., in 2015-1838 signed on May 10, 2017, 2 Pages.
In re: Nuvasive, Inc., in 2015-1839, 2015-1840 signed on May 10, 2017, 2 Pages.
In re: Nuvasive, Inc., in 2015-1841 decided on May 31, 2017, 16 Pages.
In re: Nuvasive, Inc., in 2015-1842, 2015-1843 signed on May 10, 2017, 2 Pages.
In re: Warsaw Orthopedic, Inc. in 15-1050 filed Oct. 14, 2014.
In re: Warsaw Orthopedic, Inc. in 15-1058 filed Oct. 17, 2014.
INS-1 Guide Dec. 31, 2000, Part I.
INS-1 Guide Dec. 31, 2000, Part II.
International Search Report dated Jan. 12, 2011 for International Application No. PCT/US2010/002960.
International Search Report dated Feb. 9, 2005 for International Application PCT/US2004/031768.
International Search Report dated Jul. 24, 2012 for International Application No. PCT/US2012/022600.
International Search Report dated Oct. 29, 2012 for International Application No. PCT/US2012/051480.
International Search Report dated Dec. 13, 2011 for International Application No. PCT/US2011/001489.
International Search Report dated Dec. 24, 2008 for International Application No. PCT/US2008/012121.
International Search Report dated Mar. 23, 2011 for International Application No. PCT/US2010/002951.
Notice of Allowance dated Mar. 30, 2017 for U.S. Appl. No. 14/263,797.
Notice of Allowance dated Apr. 12, 2017 for U.S. Appl. No. 15/272,071.
NuVasive, Inc. v. Medtronic, Inc. in 15-1674 filed May 26, 2015, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
NuVasive, Inc. v. Medtronic, Inc. in 15-1712 filed Jun. 8, 2015, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
NuVasive, Inc. v. Warsaw Orthopedic, Inc. in 15-1049 filed Oct. 14, 2014, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Office Action dated Jan. 11, 2012 for U.S. Appl. No. 11/982,185.
Office Action dated Jan. 12, 2012 for U.S. Appl. No. 11/489,020.
Office Action dated Jan. 21, 2011 for U.S. Appl. No. 11/982,185.
Office Action dated Feb. 26, 2016 for U.S. Appl. No. 14/622,585.
Office Action dated Mar. 16, 2009 for U.S. Appl. No. 11/489,020.
Office Action dated Mar. 29, 2017 for U.S. Appl. No. 15/448,395.
Office Action dated Apr. 5, 2017 for U.S. Appl. No. 15/445,854.
Office Action dated Apr. 6, 2017 for U.S. Appl. No. 15/439,889.
Office Action dated Apr. 7, 2017 for U.S. Appl. No. 15/059,215.
Office Action dated Apr. 29, 2010 for U.S. Appl. No. 11/982,185.
Office Action dated May 6, 2010 for U.S. Appl. No. 11/489,020.
Office Action dated May 8, 2014 for U.S. Appl. No. 13/964,836.
Office Action dated Jun. 17, 2009 for U.S. Appl. No. 11/982,185.
Office Action dated Jun. 20, 2017 for U.S. Appl. No. 15/424,492.
Office Action dated Jun. 20, 2017 for U.S. Appl. No. 15/424,612.
Office Action dated Sep. 15, 2008 for U.S. Appl. No. 11/489,020.
Office Action dated Sep. 19, 2016 for U.S. Appl. No. 14/263,797.
Office Action dated Sep. 23, 2016 for U.S. Appl. No. 14/622,585.
Office Action dated Oct. 9, 2009 for U.S. Appl. No. 11/489,020.
Office Action dated Oct. 20, 2016 for U.S. Appl. No. 14/297,369.
Office Action dated Nov. 28, 2016 for U.S. Appl. No. 14/994,640.
Office Action dated Nov. 4, 2016 for U.S. Appl. No. 14/297,438.
Office Action dated Dec. 19, 2014 for U.S. Appl. No. 13/964,836.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00504 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00506 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00507 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00508 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00071 filed Oct. 16, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00487 filed Mar. 5, 2014, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00206 filed Mar. 22, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00208 filed Mar. 22, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00395 filed Jun. 27, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00396 filed Jun. 27, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2015-00502 filed Dec. 24, 2014, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 12-1263 filed Mar. 15, 2012.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 12-1266 filed Mar. 15, 2012.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 13-1576 filed Aug. 21, 2013.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 13-1577 filed Aug. 21, 2013.

Related Publications (1)

	Number	Date	Country
	20150150693 A1	Jun 2015	US

Provisional Applications (1)

	Number	Date	Country
	60325424	Sep 2001	US

Continuations (8)

	Number	Date	Country
Parent	14278862	May 2014	US
Child	14618438		US
Parent	13763816	Feb 2013	US
Child	14278862		US
Parent	13762624	Feb 2013	US
Child	13763816		US
Parent	13568236	Aug 2012	US
Child	13762624		US
Parent	13215791	Aug 2011	US
Child	13568236		US
Parent	12423559	Apr 2009	US
Child	13215791		US
Parent	10809280	Mar 2004	US
Child	12423559		US
Parent	PCT/US02/30617	Sep 2002	US
Child	10809280		US

Systems and methods for performing surgical procedures and assessments

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

CPC

Field of Search

CPC

International Classifications

Disclaimer

Term Extension

Abstract